Xstrata Copper has successfully extended the lifespan of Ernest Henry mines by
another 12 years by moving its operations underground The open pit mine, a
AUD589 million project has since progressed to underground mining and magnetite
processing. This move is expected to create and sustain jobs in north-west
Queensland. During the construction phase, three million tonnes of annual ore
output will produce 25,000 tonnes of copper and 35,000 ounces of gold in
concentrate. By 2013, production is expected to double to six million tonnes of
ore, translating into 50,000 tonnes of copper and 70,000 ounces of gold in
concentrate. The construction phase will see employment of 330 full-time staff.
Another 70 will be added to the payroll once the major shaft underground mine
and magnetite processing plant is completed in 2013. Mr Steve de Kruijff, North
Queensland Chief Operating Officer at Xstrata Copper revealed that the Ernest
Henry operation is a critical part of Xstrata Copper North Queensland's
integrated business, which as a whole contributed around $1.34 billion to the
Queensland economy and employed nearly 4,000 people in 2010. He added, "Ernest
Henry Mining's transition is part of our long term operational plan that will
see significant investment in north Queensland to focus on exporting mineral
concentrates, along with the development of necessary infrastructure to increase
rail and port capacity," Asia Mining Congress 2012 is pleased to have Mr Steve
de Kruijff join us in presenting: "Australia Company Spotlight: Sustaining
Xstrata Coppers North Queensland Operations." Come hear it from Steve and
other mining professionals. Download the programme brochure now . Network and
connect with the industry leaders. Join our professionals and experts at Mining
Nuggets on Facebook.
Tuesday, December 20, 2011
Todays Dow Jones Industrial Average DJIA DJI; S&P 500; Nasdaq; Stock market Investing News Today
Stocks rallied during the last trading session in the U.S. The Dow Jones
Industrial Average , as well as the Nasdaq and S&P 500, started the day with
brighter futures and were able to slope positively throughout the course of the
last trading session. Some positive economic news posted in the U.S. and the
attention seemed to deflect negative energy stemming from the ongoing debt
crisis in the eurozone. Also, a significant rally was set off in the eurozone
last session. German consumer confidence posted better than expected as did the
results of a Spanish debt auction that took place yesterday. Stock indices were
pushed aloft by the better-than expected housing data that posted in the U.S. as
well. According to the housing report, new home construction numbers rose to an
annual rate of 685,000 in November and requests for building permits rose by 1.8
percent to 681,000. The positive eurozone close paired with the positive data
posting in the U.S. helped push U.S. composites up the ladder. Primary
indicators finished green across the board. As the trading session in the U.S.
closed out for the day, the DJIA , as well as the Nasdaq and S&P 500, finished
well above opening numbers. The DJI finished higher by 2.87 percent or positive
337.32 points at 12,103.58. The Nasdaq finished the session higher by 3.19
percent or positive 80.59 points at 2,603.73. The S&P 500 closed higher by 2.98
percent or positive by 35.95 points at 1,241.30. Frank Matto
Industrial Average , as well as the Nasdaq and S&P 500, started the day with
brighter futures and were able to slope positively throughout the course of the
last trading session. Some positive economic news posted in the U.S. and the
attention seemed to deflect negative energy stemming from the ongoing debt
crisis in the eurozone. Also, a significant rally was set off in the eurozone
last session. German consumer confidence posted better than expected as did the
results of a Spanish debt auction that took place yesterday. Stock indices were
pushed aloft by the better-than expected housing data that posted in the U.S. as
well. According to the housing report, new home construction numbers rose to an
annual rate of 685,000 in November and requests for building permits rose by 1.8
percent to 681,000. The positive eurozone close paired with the positive data
posting in the U.S. helped push U.S. composites up the ladder. Primary
indicators finished green across the board. As the trading session in the U.S.
closed out for the day, the DJIA , as well as the Nasdaq and S&P 500, finished
well above opening numbers. The DJI finished higher by 2.87 percent or positive
337.32 points at 12,103.58. The Nasdaq finished the session higher by 3.19
percent or positive 80.59 points at 2,603.73. The S&P 500 closed higher by 2.98
percent or positive by 35.95 points at 1,241.30. Frank Matto
10 Experts Pick the 10 Best Stocks for 2012
Wondering what the best stocks to buy for next year are? Well, look no further
than the 10 Best Stocks for 2012 . This InvestorPlace feature lists 10 long-term
investments from a group of money managers, market experts and financial
journalists. The 10 Best Stocks for 2012 is meant to provide buy-and-hold picks
you can purchase now and sit on for a year ideally, winding up richer on the
other side. The buy list this year is a diverse group of stocks from banks to
technology, from emerging markets to Dow components, from old favorites to a
stock that went public just a few months ago. Throughout the year, the writers
will regularly offer updates on the good, the bad and the unexpected as it
relates to their best stock for 2012. We'll find out in a year who had the
best pick but first, let's examine each writer's recommendation and what
made them pick their stock as the best investment for the New Year:
than the 10 Best Stocks for 2012 . This InvestorPlace feature lists 10 long-term
investments from a group of money managers, market experts and financial
journalists. The 10 Best Stocks for 2012 is meant to provide buy-and-hold picks
you can purchase now and sit on for a year ideally, winding up richer on the
other side. The buy list this year is a diverse group of stocks from banks to
technology, from emerging markets to Dow components, from old favorites to a
stock that went public just a few months ago. Throughout the year, the writers
will regularly offer updates on the good, the bad and the unexpected as it
relates to their best stock for 2012. We'll find out in a year who had the
best pick but first, let's examine each writer's recommendation and what
made them pick their stock as the best investment for the New Year:
Don’t Get Too Excited About Tuesday’s Romp
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace If there's one thing the market has taught us during the past four months, it's this — never underestimate its ability to do something unexpected, even logic-defying. Tuesday's 3% rally qualifies as such an event. Over the course of a pretty miserable seven-day stretch before Tuesday, the broader market had lost 4.7% of its value. In one day, it gained two-thirds of that loss back. Amazing. The reason for the bounce-back still is up for debate. A new hope for Europe's financial plight got the lion's share of the credit, though encouraging construction numbers were in that race as well. Either way, for me, the reason for the rally isn't nearly as important as the quality of it. Does it have any longevity? To fully gauge that, we have to dig much deeper into the bullish move itself. A look at the gain's overall volume is a good start, but not the complete story. Here's a closer look at the move, and what the true undertow looks like: Volume Was Just OK Click to Enlarge Contrary to popular belief and headlines like "Market Surges on High Volume,” Tuesday's volume wasn't that great. It was better than Monday's, but nothing significantly better than the average volume we've seen during the past several weeks. The NYSE's listed stocks (all its exchanges) saw 3.77 billion shares trade hands yesterday — only about 15% better than Monday's total, and about the average number since August's implosion. The other exchanges and indices told the same basic volume story on Tuesday. A red flag of a faltering rally? Usually yes, but in this case, not necessarily. While growing volume is a prerequisite for any rally, there's such a thing as too much volume. When trading volume spirals out of control and the floodgates are opened within one trading session, a huge volume spike often signals a turning point as well (sometimes for the better, and sometimes for the worse). In this case, the mediocre volume actually implies there's some meat left on the bone, so to speak. In that light, the modest-volume day isn't a liability considering the accompanying price surge, It might even be a good thing, letting us know the new uptrend can indeed last since buyers didn't empty the tank all in one shot. But, there's still far more to the story. Breadth & Depth are the 'Quality' Clues While the market's raw volume data can be deceiving, if you drill down into the market's breadth and depth, there's no place for the true undertow to hide. Breadth is just a fancy word for participation; how many stocks are actually part of the rally, versus how many are actually pointed lower (and just masked by the marketwide gains). The better the participation — as evidenced by the “advancers” — the more bullish the rally. Depth is an equally fancy word for volume. Just because a market's going higher doesn't mean it's a noteworthy rally. It might just mean there are very few sellers getting in the way at that time, and the relatively big number of buyers is making a market look a little more bullish than it actually is. Breadth and depth are measured at the exchange level, and not the marketwide level. But the NYSE's breadth and depth is a very good proxy for the overall market's health. So, we'll focus on that data set with our chart. As it turns out, Tuesday's gain is even less impressive than the modest volume would suggest. Click to Enlarge The NYSE boasted 2,763 (out of 3,197) of its listed stocks as winners yesterday. Only 371 of them lost ground. That's solid, but not dramatic. Indeed, we saw advancers reach that 2,700-ish level several times since August, and clearly none of those instances meant anything terribly bullish. As for breadth, or volume, no two data sources have the exact same number, but they all have the NYSE's “up” volume from Tuesday at just above 900 million shares. The “down” volume total was a mere 21 million shares, which is remarkably low, but the advancers' volume still is quite tepid — even lower than what we saw behind Friday's modest gain. Take a look. (For all four breadth and depth plots, the histograms show the daily data, while the overlaid moving averages are indicative of any trends.) Conclusion To be fair, the trends — as indicated by the moving averages — are turning slightly toward bullishness and slightly away from bearishness. And Tuesday certainly helped on that front. Tuesday wasn't a game-changer, though. Volume was modest, and bullish breadth and depth were moderate, at best. So no, Tuesday isn't a clarion call for the bulls. The only thing Tuesday's action is telling is us that some traders already are on Christmas vacation, and there just weren't many sellers to stand in the way. Don't get too excited just yet.
Top Oversold U.S.-Listed Chinese Stocks (Dec 20, 2011)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the latest oversold U.S.-listed Chinese stocks. Qihoo 360 Technology Co Ltd (NYSE:QIHU) is the most oversold U.S.-listed Chinese stock on Dec. 20. It was down 4.5% on the day. QIHU's upside potential is 110.8% based on brokerage analysts' average target price of $34.07. It is trading at 44.6% of its 52-week high of $36.21, and 13.0% above its 52-week low of $14.30. Country Syl Ckng Restaurant Chain Co Ltd (NYSE:CCSC) is the second most oversold U.S.-listed Chinese stock on Dec. 20. It was down 3.2% on the day. CCSC's upside potential is 72.7% based on brokerage analysts' average target price of $12.12. It is trading at 26.1% of its 52-week high of $26.85, and 2.5% above its 52-week low of $6.85. Jiayuan.com International Ltd (NASDAQ:DATE) is the third most oversold U.S.-listed Chinese stock on Dec. 20. It was down 2.7% on the day. DATE's upside potential is 163.7% based on brokerage analysts' average target price of $15.22. It is trading at 35.8% of its 52-week high of $16.12, and 0.3% above its 52-week low of $5.75. ZHONGPIN INC. (NASDAQ:HOGS) is the fourth most oversold U.S.-listed Chinese stock on Dec. 20. It was down 2.6% on the day. HOGS's upside potential is 91.6% based on brokerage analysts' average target price of $15.92. It is trading at 39.4% of its 52-week high of $21.07, and 25.9% above its 52-week low of $6.60. TAL Education Group (ADR) (NYSE:XRS) is the fifth most oversold U.S.-listed Chinese stock on Dec. 20. It was down 0.6% on the day. XRS's upside potential is 56.0% based on brokerage analysts' average target price of $15.43. It is trading at 60.9% of its 52-week high of $16.25, and 17.6% above its 52-week low of $8.41. Renren Inc (NYSE:RENN) is the sixth most oversold U.S.-listed Chinese stock on Dec. 20. It was down 0.3% on the day. RENN's upside potential is 131.6% based on brokerage analysts' average target price of $7.62. It is trading at 13.7% of its 52-week high of $24.00, and 2.5% above its 52-week low of $3.21.
The Gold Price and Silver Price had a Field Day, Gold up 1.3 Percent
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Gold Price Close Today : 1615.60 Change : 21.20 or 1.3% Silver Price Close Today : 2949.60 Change : 67.40 cents or 2.3% Gold Silver Ratio Today : 54.774 Change : -0.545 or -1.0% Silver Gold Ratio Today : 0.01826 Change : 0.000180 or 1.0% Platinum Price Close Today : 1432.00 Change : 24.70 or 1.8% Palladium Price Close Today : 625.45 Change : 16.80 or 2.8% S&P 500 : 1,205.35 Change : -14.31 or -1.2% Dow In GOLD$ : $150.55 Change : $ (3.28) or -2.1% Dow in GOLD oz : 7.283 Change : -0.159 or -2.1% Dow in SILVER oz : 398.91 Change : -12.80 or -3.1% Dow Industrial : 11,766.26 Change : -100.13 or -0.8% US Dollar Index : 79.83 Change : -0.421 or -0.5% Mercy! The SILVER and GOLD PRICE had a field day. On Comex the GOLD PRICE rose $21.20 (1.3%), smashed through $1,605 resistance, and closed $1,615.60. Silver rose 67.4c (2.3%)to 2949.6. That’s good, but it ain’t exactly crossing over Jordan into the promised land just yet. Above lies resistance at $1,625, then $1,650, then $1,687. If this rally exceeds $1,675 it will command our attention and respect. Till then it earns only watching. And we’ll find out something about that last low ($1,562.50) when this little rally-ette runs out of steam. The SILVER PRICE shone with a 2.3% rise, and Mondays trading looks like some sort of bottom — permanent or interim is another question — but now the rally meets real resistance at 2980. Must clear that barrier to maintain its reputation. To give y’all a nearer idea where today brings silver, think on this: the down trend line stands overhead at 3050c. Today’s high reached only 2959c. All today’s work was constructive, but settled nothing. Silver and gold remain in downtrends. They are only corrective downtrends, interrupting a primary bull market (uptrend), but down for the nonce still. Appears I got it exactly wrong at the exact bottom, facing yesterday’s outlook to today’s performance. Ahh, the obese female hath not yet sung her aria, so let me cover my embarrassment with patience. Euphoria’s mother today was a pledge from Europe to pony up 150 bn euros ($196 bn), which they don’t have, to the IMF to apply to the European debt crisis, where the questionable debt amounts to $3 trillion, 15 times the magnanimous contribution. ECB also widened its support for bond markets (NYT-speak for I don’t know what), German economic confidence indicators rose, and the US Commerce Dep’t said builders broke ground on 9.3% more new homes in November than in October, while building permits jumped 5.7%. This number is rock solid until the adjustments are published next month. Yeah, buddy! All that sounds like the world economy and the European crisis turning the corner to me. Right. Anyhow, that’s how markets reacted as if “Happy Days Are Here Again.” STOCK buyers fell into a frenzy like lemmings on their way to the coast. Dow jumped 337.32 points or 2.8% to 12,103.58. S&P 500 rose 2.98% (35.95) to 1,241.30. This positions stocks for a triple top just above 12,200. SOURPUSS! You might say, You never have any- thing good to say about stocks! And you’d be right, as I have nothing good to say about any market that is in a primary down trend (bear market) and technically looks as ratty as an old 1970s burnt orange polyester leisure suit. Technically that took stocks above the 200 day moving average (11,936). Since they are already above the 50 DMA (11,835), that does give them upward momentum. At least until the next piece of bad news out of Europe sends scuttles investor hopes. Dow will not pass 12,300; S&P500 won’t rise above 1,280. I reckon time’s come for me to get more accurate and precise about the US dollar index. Today it lost 42.1 basis points, down 0.54%, to 79.829. I’ve been saying it needs to hold 80. Have I changed my mind? Nope, I’ve just sharpened my pencil. The actual support line is 79.84 – 79.70, site of the last two peaks. today the dollar came back to that line, so today’s action is not fatal. More than that, the uptrend line right now stands just a mite above 79. Long as dollar doesn’t break that, it will still be rallying. Now I’m just a natural born fool, but if I were them Nice Government Men and I wanted to boost the euro and trim the dollar, I’d wait for some nested good news, or make some up, and then I’d buy them stock futures real heavy early in the day, to make it look like some mad buying panic was carrying away the public, just to sort of spark a rally like. But what do I know? Euro today rose 0.63% to close at 1.3080. Another few points and it’ll hit my 1.3200 target where the trend line stands in its way, and stop like a wild steer running headfirst into a concrete block wall. Japanese Yen rose 0.18% to close 128.39c/Y100 (Y77.89/$1). Nothing happening there. Argentum et aurum comparenda sunt — – Gold and silver must be bought. – Franklin Sanders, The Moneychanger The-MoneyChanger.com © 2011, The Moneychanger. May not be republished in any form, including electronically, without our express permission. To avoid confusion, please remember that the comments above have a very short time horizon. Always invest with the primary trend. Gold’s primary trend is up, targeting at least $3,130.00; silver’s primary is up targeting 16:1 gold/silver ratio or $195.66; stocks’ primary trend is down, targeting Dow under 2,900 and worth only one ounce of gold; US$ or US$-denominated assets, primary trend down; real estate bubble has burst, primary trend down. WARNING AND DISCLAIMER. Be advised and warned: Do NOT use these commentaries to trade futures contracts. I don’t intend them for that or write them with that short term trading outlook. I write them for long-term investors in physical metals. Take them as entertainment, but not as a timing service for futures. NOR do I recommend investing in gold or silver Exchange Trade Funds (ETFs). Those are NOT physical metal and I fear one day one or another may go up in smoke. Unless you can breathe smoke, stay away. Call me paranoid, but the surviving rabbit is wary of traps. NOR do I recommend trading futures options or other leveraged paper gold and silver products. These are not for the inexperienced. NOR do I recommend buying gold and silver on margin or with debt. What DO I recommend? Physical gold and silver coins and bars in your own hands. One final warning: NEVER insert a 747 Jumbo Jet up your nose.
The Gold Price and Silver Price had a Field Day, Gold up 1.3 Percent
Gold Price Close Today : 1615.60 Change : 21.20 or 1.3% Silver Price Close
Today : 2949.60 Change : 67.40 cents or 2.3% Gold Silver Ratio Today : 54.774
Change : -0.545 or -1.0% Silver Gold Ratio Today : 0.01826 Change : 0.000180 or
1.0% Platinum Price Close Today : 1432.00 Change : 24.70 or 1.8% Palladium Price
Close Today : 625.45 Change : 16.80 or 2.8% S&P 500 : 1,205.35 Change : -14.31
or -1.2% Dow In GOLD$ : $150.55 Change : $ (3.28) or -2.1% Dow in GOLD oz :
7.283 Change : -0.159 or -2.1% Dow in SILVER oz : 398.91 Change : -12.80 or
-3.1% Dow Industrial : 11,766.26 Change : -100.13 or -0.8% US Dollar Index :
79.83 Change : -0.421 or -0.5% Mercy! The SILVER and GOLD PRICE had a field day.
On Comex the GOLD PRICE rose $21.20 (1.3%), smashed through $1,605 resistance,
and closed $1,615.60. Silver rose 67.4c (2.3%)to 2949.6. That's good, but it
ain't exactly crossing over Jordan into the promised land just yet. Above lies
resistance at $1,625, then $1,650, then $1,687. If this rally exceeds $1,675 it
will command our attention and respect. Till then it earns only watching. And
we'll find out something about that last low ($1,562.50) when this little
rally-ette runs out of steam. The SILVER PRICE shone with a 2.3% rise, and
Mondays trading looks like some sort of bottom -- permanent or interim is
another question -- but now the rally meets real resistance at 2980. Must clear
that barrier to maintain its reputation. To give y'all a nearer idea where today
brings silver, think on this: the down trend line stands overhead at 3050c.
Today's high reached only 2959c. All today's work was constructive, but settled
nothing. Silver and gold remain in downtrends. They are only corrective
downtrends, interrupting a primary bull market (uptrend), but down for the nonce
still. Appears I got it exactly wrong at the exact bottom, facing yesterday's
outlook to today's performance. Ahh, the obese female hath not yet sung her
aria, so let me cover my embarrassment with patience. Euphoria's mother today
was a pledge from Europe to pony up 150 bn euros ($196 bn), which they don't
have, to the IMF to apply to the European debt crisis, where the questionable
debt amounts to $3 trillion, 15 times the magnanimous contribution. ECB also
widened its support for bond markets (NYT-speak for I don't know what), German
economic confidence indicators rose, and the US Commerce Dep't said builders
broke ground on 9.3% more new homes in November than in October, while building
permits jumped 5.7%. This number is rock solid until the adjustments are
published next month. Yeah, buddy! All that sounds like the world economy and
the European crisis turning the corner to me. Right. Anyhow, that's how markets
reacted as if "Happy Days Are Here Again." STOCK buyers fell into a frenzy like
lemmings on their way to the coast. Dow jumped 337.32 points or 2.8% to
12,103.58. S&P 500 rose 2.98% (35.95) to 1,241.30. This positions stocks for a
triple top just above 12,200. SOURPUSS! You might say, You never have any- thing
good to say about stocks! And you'd be right, as I have nothing good to say
about any market that is in a primary down trend (bear market) and technically
looks as ratty as an old 1970s burnt orange polyester leisure suit. Technically
that took stocks above the 200 day moving average (11,936). Since they are
already above the 50 DMA (11,835), that does give them upward momentum. At least
until the next piece of bad news out of Europe sends scuttles investor hopes.
Dow will not pass 12,300; S&P500 won't rise above 1,280. I reckon time's come
for me to get more accurate and precise about the US dollar index. Today it lost
42.1 basis points, down 0.54%, to 79.829. I've been saying it needs to hold 80.
Have I changed my mind? Nope, I've just sharpened my pencil. The actual support
line is 79.84 - 79.70, site of the last two peaks. today the dollar came back to
that line, so today's action is not fatal. More than that, the uptrend line
right now stands just a mite above 79. Long as dollar doesn't break that, it
will still be rallying. Now I'm just a natural born fool, but if I were them
Nice Government Men and I wanted to boost the euro and trim the dollar, I'd wait
for some nested good news, or make some up, and then I'd buy them stock futures
real heavy early in the day, to make it look like some mad buying panic was
carrying away the public, just to sort of spark a rally like. But what do I
know? Euro today rose 0.63% to close at 1.3080. Another few points and it'll hit
my 1.3200 target where the trend line stands in its way, and stop like a wild
steer running headfirst into a concrete block wall. Japanese Yen rose 0.18% to
close 128.39c/Y100 (Y77.89/$1). Nothing happening there. Argentum et aurum
comparenda sunt -- -- Gold and silver must be bought. - Franklin Sanders, The
Moneychanger The-MoneyChanger.com © 2011, The Moneychanger. May not be
republished in any form, including electronically, without our express
permission. To avoid confusion, please remember that the comments above have a
very short time horizon. Always invest with the primary trend. Gold's primary
trend is up, targeting at least $3,130.00; silver's primary is up targeting 16:1
gold/silver ratio or $195.66; stocks' primary trend is down, targeting Dow under
2,900 and worth only one ounce of gold; US$ or US$-denominated assets, primary
trend down; real estate bubble has burst, primary trend down. WARNING AND
DISCLAIMER. Be advised and warned: Do NOT use these commentaries to trade
futures contracts. I don't intend them for that or write them with that short
term trading outlook. I write them for long-term investors in physical metals.
Take them as entertainment, but not as a timing service for futures. NOR do I
recommend investing in gold or silver Exchange Trade Funds (ETFs). Those are NOT
physical metal and I fear one day one or another may go up in smoke. Unless you
can breathe smoke, stay away. Call me paranoid, but the surviving rabbit is wary
of traps. NOR do I recommend trading futures options or other leveraged paper
gold and silver products. These are not for the inexperienced. NOR do I
recommend buying gold and silver on margin or with debt. What DO I recommend?
Physical gold and silver coins and bars in your own hands. One final warning:
NEVER insert a 747 Jumbo Jet up your nose.
Today : 2949.60 Change : 67.40 cents or 2.3% Gold Silver Ratio Today : 54.774
Change : -0.545 or -1.0% Silver Gold Ratio Today : 0.01826 Change : 0.000180 or
1.0% Platinum Price Close Today : 1432.00 Change : 24.70 or 1.8% Palladium Price
Close Today : 625.45 Change : 16.80 or 2.8% S&P 500 : 1,205.35 Change : -14.31
or -1.2% Dow In GOLD$ : $150.55 Change : $ (3.28) or -2.1% Dow in GOLD oz :
7.283 Change : -0.159 or -2.1% Dow in SILVER oz : 398.91 Change : -12.80 or
-3.1% Dow Industrial : 11,766.26 Change : -100.13 or -0.8% US Dollar Index :
79.83 Change : -0.421 or -0.5% Mercy! The SILVER and GOLD PRICE had a field day.
On Comex the GOLD PRICE rose $21.20 (1.3%), smashed through $1,605 resistance,
and closed $1,615.60. Silver rose 67.4c (2.3%)to 2949.6. That's good, but it
ain't exactly crossing over Jordan into the promised land just yet. Above lies
resistance at $1,625, then $1,650, then $1,687. If this rally exceeds $1,675 it
will command our attention and respect. Till then it earns only watching. And
we'll find out something about that last low ($1,562.50) when this little
rally-ette runs out of steam. The SILVER PRICE shone with a 2.3% rise, and
Mondays trading looks like some sort of bottom -- permanent or interim is
another question -- but now the rally meets real resistance at 2980. Must clear
that barrier to maintain its reputation. To give y'all a nearer idea where today
brings silver, think on this: the down trend line stands overhead at 3050c.
Today's high reached only 2959c. All today's work was constructive, but settled
nothing. Silver and gold remain in downtrends. They are only corrective
downtrends, interrupting a primary bull market (uptrend), but down for the nonce
still. Appears I got it exactly wrong at the exact bottom, facing yesterday's
outlook to today's performance. Ahh, the obese female hath not yet sung her
aria, so let me cover my embarrassment with patience. Euphoria's mother today
was a pledge from Europe to pony up 150 bn euros ($196 bn), which they don't
have, to the IMF to apply to the European debt crisis, where the questionable
debt amounts to $3 trillion, 15 times the magnanimous contribution. ECB also
widened its support for bond markets (NYT-speak for I don't know what), German
economic confidence indicators rose, and the US Commerce Dep't said builders
broke ground on 9.3% more new homes in November than in October, while building
permits jumped 5.7%. This number is rock solid until the adjustments are
published next month. Yeah, buddy! All that sounds like the world economy and
the European crisis turning the corner to me. Right. Anyhow, that's how markets
reacted as if "Happy Days Are Here Again." STOCK buyers fell into a frenzy like
lemmings on their way to the coast. Dow jumped 337.32 points or 2.8% to
12,103.58. S&P 500 rose 2.98% (35.95) to 1,241.30. This positions stocks for a
triple top just above 12,200. SOURPUSS! You might say, You never have any- thing
good to say about stocks! And you'd be right, as I have nothing good to say
about any market that is in a primary down trend (bear market) and technically
looks as ratty as an old 1970s burnt orange polyester leisure suit. Technically
that took stocks above the 200 day moving average (11,936). Since they are
already above the 50 DMA (11,835), that does give them upward momentum. At least
until the next piece of bad news out of Europe sends scuttles investor hopes.
Dow will not pass 12,300; S&P500 won't rise above 1,280. I reckon time's come
for me to get more accurate and precise about the US dollar index. Today it lost
42.1 basis points, down 0.54%, to 79.829. I've been saying it needs to hold 80.
Have I changed my mind? Nope, I've just sharpened my pencil. The actual support
line is 79.84 - 79.70, site of the last two peaks. today the dollar came back to
that line, so today's action is not fatal. More than that, the uptrend line
right now stands just a mite above 79. Long as dollar doesn't break that, it
will still be rallying. Now I'm just a natural born fool, but if I were them
Nice Government Men and I wanted to boost the euro and trim the dollar, I'd wait
for some nested good news, or make some up, and then I'd buy them stock futures
real heavy early in the day, to make it look like some mad buying panic was
carrying away the public, just to sort of spark a rally like. But what do I
know? Euro today rose 0.63% to close at 1.3080. Another few points and it'll hit
my 1.3200 target where the trend line stands in its way, and stop like a wild
steer running headfirst into a concrete block wall. Japanese Yen rose 0.18% to
close 128.39c/Y100 (Y77.89/$1). Nothing happening there. Argentum et aurum
comparenda sunt -- -- Gold and silver must be bought. - Franklin Sanders, The
Moneychanger The-MoneyChanger.com © 2011, The Moneychanger. May not be
republished in any form, including electronically, without our express
permission. To avoid confusion, please remember that the comments above have a
very short time horizon. Always invest with the primary trend. Gold's primary
trend is up, targeting at least $3,130.00; silver's primary is up targeting 16:1
gold/silver ratio or $195.66; stocks' primary trend is down, targeting Dow under
2,900 and worth only one ounce of gold; US$ or US$-denominated assets, primary
trend down; real estate bubble has burst, primary trend down. WARNING AND
DISCLAIMER. Be advised and warned: Do NOT use these commentaries to trade
futures contracts. I don't intend them for that or write them with that short
term trading outlook. I write them for long-term investors in physical metals.
Take them as entertainment, but not as a timing service for futures. NOR do I
recommend investing in gold or silver Exchange Trade Funds (ETFs). Those are NOT
physical metal and I fear one day one or another may go up in smoke. Unless you
can breathe smoke, stay away. Call me paranoid, but the surviving rabbit is wary
of traps. NOR do I recommend trading futures options or other leveraged paper
gold and silver products. These are not for the inexperienced. NOR do I
recommend buying gold and silver on margin or with debt. What DO I recommend?
Physical gold and silver coins and bars in your own hands. One final warning:
NEVER insert a 747 Jumbo Jet up your nose.
Buffett Got Burned on Bank of America, and There’s No Bottom in Sight
Bank of America (NYSE: BAC ) is one of the most hated companies in America .
Aside from past robo-signings, proposed fees and general shenanigans amid the
financial crisis, the company continues to prove all of its critics right with
continued missteps and ugly headlines. Its earnings can't be trusted and its
CEO, Brian Moynihan, is completely out of touch . So it's no surprise that
despite briefly breaking below the $5 mark , nobody came out yesterday and
labeled Bank of America stock as a bargain. An intraday low of $4.92 and a close
of $4.99 marked the lowest levels for the stock since March 2009 the bear
market bottom that saw stocks rebound with a vengeance. The S&P was at 676 now
its at 1,234. But while the major indices have doubled, Bank of America is just
as ugly to investors now as it was during those dark days two-and-a-half years
ago. Very few stocks are at 2009 levels. Some of them deserve to be there
Eastman Kodak (NYSE: EK ), for instance, which appears to be doomed for
bankruptcy without extraordinary intervention. You simply can't lose money and
have debt that large and expect to stick around. However, Bank of America is not
like Kodak. Aside from a brutal second quarter in 2009 when it took some $20
billion in write-downs, it is nominally profitable. It trades for a paltry 0.25
price-to-book ratio while Wells Fargo (NYSE: WFC ) is at 1.0 and JP Morgan
Chase (NYSE: JPM ) is at 0.6! So, BAC shares could be a bargain at $5, right?
Right? Unfortunately, hardly anyone on Wall Street is buying that argument.
It's remarkable how few people came out of the woodwork yesterday and today
trumpeting Bank of America's bargain potential. In fact, the biggest talking
point I've noticed is about how Warren Buffett might be taking a bath on his
risky play in Bank of America. BofA gave Buffett warrants to buy a whopping 700
million shares of common stock at $7.14 when the Oracle of Omaha plowed $5
billion into preferred shares of BAC stock . Obviously those warrants don't
really matter when shares are almost 30% under that strike price. By some
estimates, Buffett has lost $1.5 billion on the deal since that August buy-in,
when shares were around $6. But don't weep for Warren his nice 6% dividend on
his shares will keep paying him, and BAC stock has moved up from under $5 today
and could keep rising. But the fact that Buffett could ride in on his white
horse with the "smart money," buying Bank of America at $6 only to see
shares hit $5 four months later … that's enough to make every investor think
twice. As result, Bank of America should be seen as an extremely short-term play
for only the most aggressive traders … akin to Sprint Nextel (NYSE: S ),
Sirius XM (NASDAQ: SIRI ) or other big-name stocks that are super cheap and
super volatile. As for the buy-and-hold crowd, sit this out for now. Bank of
America is the ultimate value trap. Plenty of folks think Bank of America is
getting what it deserves as some kind of karmic payback for its misdeeds. While
there might be some cosmic justice here, the reality is that the only true
recovery will see banks recover, too . Here's hoping Bank of America turns it
around not for shareholders, but because we simply can't afford to see
another financial behemoth go under. Jeff Reeves is the editor of
InvestorPlace.com. Write him at editor@investorplace.com , follow him on Twitter
via @JeffReevesIP and become a fan of InvestorPlace on Facebook . Jeff Reeves
holds a position in Alcoa, but no other publicly traded stocks.
Aside from past robo-signings, proposed fees and general shenanigans amid the
financial crisis, the company continues to prove all of its critics right with
continued missteps and ugly headlines. Its earnings can't be trusted and its
CEO, Brian Moynihan, is completely out of touch . So it's no surprise that
despite briefly breaking below the $5 mark , nobody came out yesterday and
labeled Bank of America stock as a bargain. An intraday low of $4.92 and a close
of $4.99 marked the lowest levels for the stock since March 2009 the bear
market bottom that saw stocks rebound with a vengeance. The S&P was at 676 now
its at 1,234. But while the major indices have doubled, Bank of America is just
as ugly to investors now as it was during those dark days two-and-a-half years
ago. Very few stocks are at 2009 levels. Some of them deserve to be there
Eastman Kodak (NYSE: EK ), for instance, which appears to be doomed for
bankruptcy without extraordinary intervention. You simply can't lose money and
have debt that large and expect to stick around. However, Bank of America is not
like Kodak. Aside from a brutal second quarter in 2009 when it took some $20
billion in write-downs, it is nominally profitable. It trades for a paltry 0.25
price-to-book ratio while Wells Fargo (NYSE: WFC ) is at 1.0 and JP Morgan
Chase (NYSE: JPM ) is at 0.6! So, BAC shares could be a bargain at $5, right?
Right? Unfortunately, hardly anyone on Wall Street is buying that argument.
It's remarkable how few people came out of the woodwork yesterday and today
trumpeting Bank of America's bargain potential. In fact, the biggest talking
point I've noticed is about how Warren Buffett might be taking a bath on his
risky play in Bank of America. BofA gave Buffett warrants to buy a whopping 700
million shares of common stock at $7.14 when the Oracle of Omaha plowed $5
billion into preferred shares of BAC stock . Obviously those warrants don't
really matter when shares are almost 30% under that strike price. By some
estimates, Buffett has lost $1.5 billion on the deal since that August buy-in,
when shares were around $6. But don't weep for Warren his nice 6% dividend on
his shares will keep paying him, and BAC stock has moved up from under $5 today
and could keep rising. But the fact that Buffett could ride in on his white
horse with the "smart money," buying Bank of America at $6 only to see
shares hit $5 four months later … that's enough to make every investor think
twice. As result, Bank of America should be seen as an extremely short-term play
for only the most aggressive traders … akin to Sprint Nextel (NYSE: S ),
Sirius XM (NASDAQ: SIRI ) or other big-name stocks that are super cheap and
super volatile. As for the buy-and-hold crowd, sit this out for now. Bank of
America is the ultimate value trap. Plenty of folks think Bank of America is
getting what it deserves as some kind of karmic payback for its misdeeds. While
there might be some cosmic justice here, the reality is that the only true
recovery will see banks recover, too . Here's hoping Bank of America turns it
around not for shareholders, but because we simply can't afford to see
another financial behemoth go under. Jeff Reeves is the editor of
InvestorPlace.com. Write him at editor@investorplace.com , follow him on Twitter
via @JeffReevesIP and become a fan of InvestorPlace on Facebook . Jeff Reeves
holds a position in Alcoa, but no other publicly traded stocks.
Top Oversold U.S.-Listed Chinese Stocks (Dec 20, 2011)
Below are the latest oversold U.S.-listed Chinese stocks. Qihoo 360 Technology
Co Ltd (NYSE:QIHU) is the most oversold U.S.-listed Chinese stock on Dec. 20. It
was down 4.5% on the day. QIHUs upside potential is 110.8% based on brokerage
analysts average target price of $34.07. It is trading at 44.6% of its 52-week
high of $36.21, and 13.0% above its 52-week low of $14.30. Country Syl Ckng
Restaurant Chain Co Ltd (NYSE:CCSC) is the second most oversold U.S.-listed
Chinese stock on Dec. 20. It was down 3.2% on the day. CCSCs upside potential is
72.7% based on brokerage analysts average target price of $12.12. It is trading
at 26.1% of its 52-week high of $26.85, and 2.5% above its 52-week low of $6.85.
Jiayuan.com International Ltd (NASDAQ:DATE) is the third most oversold
U.S.-listed Chinese stock on Dec. 20. It was down 2.7% on the day. DATEs upside
potential is 163.7% based on brokerage analysts average target price of $15.22.
It is trading at 35.8% of its 52-week high of $16.12, and 0.3% above its 52-week
low of $5.75. ZHONGPIN INC. (NASDAQ:HOGS) is the fourth most oversold
U.S.-listed Chinese stock on Dec. 20. It was down 2.6% on the day. HOGSs upside
potential is 91.6% based on brokerage analysts average target price of $15.92.
It is trading at 39.4% of its 52-week high of $21.07, and 25.9% above its
52-week low of $6.60. TAL Education Group (ADR) (NYSE:XRS) is the fifth most
oversold U.S.-listed Chinese stock on Dec. 20. It was down 0.6% on the day. XRSs
upside potential is 56.0% based on brokerage analysts average target price of
$15.43. It is trading at 60.9% of its 52-week high of $16.25, and 17.6% above
its 52-week low of $8.41. Renren Inc (NYSE:RENN) is the sixth most oversold
U.S.-listed Chinese stock on Dec. 20. It was down 0.3% on the day. RENNs upside
potential is 131.6% based on brokerage analysts average target price of $7.62.
It is trading at 13.7% of its 52-week high of $24.00, and 2.5% above its 52-week
low of $3.21.
Co Ltd (NYSE:QIHU) is the most oversold U.S.-listed Chinese stock on Dec. 20. It
was down 4.5% on the day. QIHUs upside potential is 110.8% based on brokerage
analysts average target price of $34.07. It is trading at 44.6% of its 52-week
high of $36.21, and 13.0% above its 52-week low of $14.30. Country Syl Ckng
Restaurant Chain Co Ltd (NYSE:CCSC) is the second most oversold U.S.-listed
Chinese stock on Dec. 20. It was down 3.2% on the day. CCSCs upside potential is
72.7% based on brokerage analysts average target price of $12.12. It is trading
at 26.1% of its 52-week high of $26.85, and 2.5% above its 52-week low of $6.85.
Jiayuan.com International Ltd (NASDAQ:DATE) is the third most oversold
U.S.-listed Chinese stock on Dec. 20. It was down 2.7% on the day. DATEs upside
potential is 163.7% based on brokerage analysts average target price of $15.22.
It is trading at 35.8% of its 52-week high of $16.12, and 0.3% above its 52-week
low of $5.75. ZHONGPIN INC. (NASDAQ:HOGS) is the fourth most oversold
U.S.-listed Chinese stock on Dec. 20. It was down 2.6% on the day. HOGSs upside
potential is 91.6% based on brokerage analysts average target price of $15.92.
It is trading at 39.4% of its 52-week high of $21.07, and 25.9% above its
52-week low of $6.60. TAL Education Group (ADR) (NYSE:XRS) is the fifth most
oversold U.S.-listed Chinese stock on Dec. 20. It was down 0.6% on the day. XRSs
upside potential is 56.0% based on brokerage analysts average target price of
$15.43. It is trading at 60.9% of its 52-week high of $16.25, and 17.6% above
its 52-week low of $8.41. Renren Inc (NYSE:RENN) is the sixth most oversold
U.S.-listed Chinese stock on Dec. 20. It was down 0.3% on the day. RENNs upside
potential is 131.6% based on brokerage analysts average target price of $7.62.
It is trading at 13.7% of its 52-week high of $24.00, and 2.5% above its 52-week
low of $3.21.
Gold Back Above $1,600 on Positive Housing, Euro Zone News
Gold, silver and miners were all posting strong gains Tuesday morning off the
back of good news on Spanish bonds and the German economy, as well as a 9.3%
jump in U.S. November housing starts , albeit from close to record lows, to a
seasonally adjusted 685,000 the highest level since April 2010. Building
permits surged 5.7% from October and a whopping 20.7% since last November. Spot
gold was back over $1,600 per ounce and more than 1.3% higher at 10:50 a.m.,
with a bid price of $1,614.90 and an ask price of $1,615.90. Spot gold traded as
high as $1,618 and as low as $1,602.20 this morning. The London afternoon
reference price fix came in at $1,613.50, according to Kitco market data . Spot
silver was up more than 2.35%, bid at $29.48 per ounce with an ask price of
$29.58. The morning high as of time of writing was $29.62, and the low was
$29.11. Tuesdays reference price was set at $29.28 in the London a.m. Gold
bullion prices had rallied in the London a.m. , as well, up 2.8% from last weeks
low, though one trader noted that liquidity remained light, according to
BullionVaults London Gold Report. Short-term the (precious metals) complex is
likely to remain vulnerable to bouts of long liquidation amid concerns over
funding levels, an analyst at Swiss refiner MKS said. Turning to exchange
trading, gold and silver trusts were making good headway. The SPDR Gold Trust
(NYSE: GLD ) was showing gains of around 1.5%. The iShares Gold Trust (NYSE: IAU
) was up some 1.35%. The iShares Silver Trust (NYSE: SLV ) was around 2.8%
lower. Gold and silver mining ETFs were surging higher. The Market Vectors Gold
Miners ETF (NYSE: GDX ) was moving sharply higher, up more than 3.6%. The Market
Vectors Junior Gold Miners ETF (NYSE: GDXJ ) was up over 6%. The Global X Silver
Miners ETF (NYSE: SIL ) was more than 4.1% higher. Gold mining shares also were
showing strong gains. Agnico-Eagle Mines (NYSE: AEM ) was showing gains of some
4.8%. Barrick Gold (NYSE: ABX ) was up around 4%. Eldorado Gold (NYSE: EGO ) was
up nearly 2.5% higher. Goldcorp (NYSE: GG ) was nearly 3.6% higher. Newmont
Mining (NYSE: NEM ) was more than 2.7% higher. NovaGold Resources (AMEX: NG )
was up about 4.5%. Silver mining shares were surging higher as well. Shares of
Hecla Mining (NYSE: HL ) were recovering strongly following news of an accident
at its Lucky Friday Mine in Idaho last week in which seven miners were injured
after a seismic event resulted in a rock burst. The U.S. Mine Safety and Health
Administration has temporarily shut down the mine as it conducts its
investigation. Coeur dAlene Mines (NYSE: CDE ) was moving higher, up around
6.3%. Hecla Mining was up more than 7.8%. Pan American Silver (NASDAQ: PAAS )
was some 4.7% higher. Silver Wheaton (NYSE: SLW ) was showing gains of more than
5%. Silver Standard Resources (NASDAQ: SSRI ) was up around 5.8%. As of this
writing, Andrew Burger did not hold a position in any of the aforementioned
securities. Adrian Ash of BullionVault contributed to this report.
back of good news on Spanish bonds and the German economy, as well as a 9.3%
jump in U.S. November housing starts , albeit from close to record lows, to a
seasonally adjusted 685,000 the highest level since April 2010. Building
permits surged 5.7% from October and a whopping 20.7% since last November. Spot
gold was back over $1,600 per ounce and more than 1.3% higher at 10:50 a.m.,
with a bid price of $1,614.90 and an ask price of $1,615.90. Spot gold traded as
high as $1,618 and as low as $1,602.20 this morning. The London afternoon
reference price fix came in at $1,613.50, according to Kitco market data . Spot
silver was up more than 2.35%, bid at $29.48 per ounce with an ask price of
$29.58. The morning high as of time of writing was $29.62, and the low was
$29.11. Tuesdays reference price was set at $29.28 in the London a.m. Gold
bullion prices had rallied in the London a.m. , as well, up 2.8% from last weeks
low, though one trader noted that liquidity remained light, according to
BullionVaults London Gold Report. Short-term the (precious metals) complex is
likely to remain vulnerable to bouts of long liquidation amid concerns over
funding levels, an analyst at Swiss refiner MKS said. Turning to exchange
trading, gold and silver trusts were making good headway. The SPDR Gold Trust
(NYSE: GLD ) was showing gains of around 1.5%. The iShares Gold Trust (NYSE: IAU
) was up some 1.35%. The iShares Silver Trust (NYSE: SLV ) was around 2.8%
lower. Gold and silver mining ETFs were surging higher. The Market Vectors Gold
Miners ETF (NYSE: GDX ) was moving sharply higher, up more than 3.6%. The Market
Vectors Junior Gold Miners ETF (NYSE: GDXJ ) was up over 6%. The Global X Silver
Miners ETF (NYSE: SIL ) was more than 4.1% higher. Gold mining shares also were
showing strong gains. Agnico-Eagle Mines (NYSE: AEM ) was showing gains of some
4.8%. Barrick Gold (NYSE: ABX ) was up around 4%. Eldorado Gold (NYSE: EGO ) was
up nearly 2.5% higher. Goldcorp (NYSE: GG ) was nearly 3.6% higher. Newmont
Mining (NYSE: NEM ) was more than 2.7% higher. NovaGold Resources (AMEX: NG )
was up about 4.5%. Silver mining shares were surging higher as well. Shares of
Hecla Mining (NYSE: HL ) were recovering strongly following news of an accident
at its Lucky Friday Mine in Idaho last week in which seven miners were injured
after a seismic event resulted in a rock burst. The U.S. Mine Safety and Health
Administration has temporarily shut down the mine as it conducts its
investigation. Coeur dAlene Mines (NYSE: CDE ) was moving higher, up around
6.3%. Hecla Mining was up more than 7.8%. Pan American Silver (NASDAQ: PAAS )
was some 4.7% higher. Silver Wheaton (NYSE: SLW ) was showing gains of more than
5%. Silver Standard Resources (NASDAQ: SSRI ) was up around 5.8%. As of this
writing, Andrew Burger did not hold a position in any of the aforementioned
securities. Adrian Ash of BullionVault contributed to this report.
Gold Futures Climb $21, Eye Key Technical Level
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Gold futures settled substantially higher on Tuesday as the COMEX February 2012 contract climbed $20.90, or 1.3%, to $1,617.60 per ounce.
Todays Dow Jones Industrial Average DJIA DJI; Nasdaq; S&P 500; Stock Market Investing USA Global Economic News Mid-Day Today
XCSFDHG46767FHJHJF
dow2664 The Dow Jones Industrial Average , along with the Nasdaq and S&P 500 index, finished the opening trading session of the week on the negative side of break-even. The primary sources of negative energy in the marketplace last session stemmed from the ongoing debt crisis in Europe and the hit taken by major banks across the nation. Specifically, Bank of America dropped below $5 per share which was one of the lowest share values seen for the company in years. After news of this negative action spread, stocks spun lower for the day in the U.S. Prior to opening bell this morning though, futures for the DJIA , along with the Nasdaq and the S&P 500, were posting in the green. Global indices were mixed at this point. The Nikkei in Japan and the Hang Seng in Hong Kong closed higher, while the Shanghai Composite finished in the red. European stocks were trending mixed as well. As the trading session reached the mid-day mark in the U.S., the Dow Jones Industrial Average was posting green by 2.3 percent at 12036.64. The Nasdaq was posting green by 2.68 percent at 2590.65 and the S&P 500 was posting green by 2.51 percent at 1235.59. Frank Matto
Top-Performing U.S.-Listed Chinese Stocks (Dec 20, 2011)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the latest top-performing U.S.-listed Chinese stocks. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) is the best-performing U.S.-listed Chinese stock on Dec. 20. It was up 16.1% on the day. YGE's upside potential is 28.6% based on brokerage analysts' average target price of $5.29. It is trading at 30.2% of its 52-week high of $13.59, and 49.5% above its 52-week low of $2.75. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) is the second best-performing U.S.-listed Chinese stock on Dec. 20. It was up 13.8% on the day. JASO's upside potential is 124.6% based on brokerage analysts' average target price of $3.14. It is trading at 16.3% of its 52-week high of $8.57, and 15.7% above its 52-week low of $1.21. Trina Solar Limited (ADR) (NYSE:TSL) is the third best-performing U.S.-listed Chinese stock on Dec. 20. It was up 10.4% on the day. TSL's upside potential is 84.0% based on brokerage analysts' average target price of $13.07. It is trading at 22.8% of its 52-week high of $31.08, and 34.5% above its 52-week low of $5.28. E Commerce China Dangdang Inc (ADR) (NYSE:DANG) is the fourth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 9.1% on the day. DANG's upside potential is 116.5% based on brokerage analysts' average target price of $9.83. It is trading at 12.5% of its 52-week high of $36.40, and 10.5% above its 52-week low of $4.11. Spreadtrum Communications, Inc (ADR) (NASDAQ:SPRD) is the fifth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 8.9% on the day. SPRD's upside potential is 43.0% based on brokerage analysts' average target price of $30.58. It is trading at 71.3% of its 52-week high of $29.98, and 148.9% above its 52-week low of $8.59. ReneSola Ltd. (ADR) (NYSE:SOL) is the sixth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 8.8% on the day. SOL's upside potential is 77.7% based on brokerage analysts' average target price of $2.86. It is trading at 12.2% of its 52-week high of $13.25, and 11.0% above its 52-week low of $1.45. iSoftStone Holdings Ltd (ADR) (NYSE:ISS) is the seventh best-performing U.S.-listed Chinese stock on Dec. 20. It was up 8.5% on the day. ISS's upside potential is 104.5% based on brokerage analysts' average target price of $17.20. It is trading at 37.2% of its 52-week high of $22.63, and 48.6% above its 52-week low of $5.66. Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) is the eighth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 8.3% on the day. STP's upside potential is 89.4% based on brokerage analysts' average target price of $4.43. It is trading at 21.6% of its 52-week high of $10.83, and 37.6% above its 52-week low of $1.70. Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the ninth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 6.2% on the day. BIDU's upside potential is 55.3% based on brokerage analysts' average target price of $183.86. It is trading at 71.3% of its 52-week high of $165.96, and 25.5% above its 52-week low of $94.33. New Oriental Education & Tech Grp (ADR) (NYSE:EDU) is the 10th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 6.0% on the day. EDU's upside potential is 55.1% based on brokerage analysts' average target price of $35.30. It is trading at 65.4% of its 52-week high of $34.77, and 10.4% above its 52-week low of $20.61. Perfect World Co., Ltd. (ADR) (NASDAQ:PWRD) is the 11th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 5.8% on the day. PWRD's upside potential is 111.3% based on brokerage analysts' average target price of $24.00. It is trading at 39.0% of its 52-week high of $29.10, and 26.2% above its 52-week low of $9.00. SINA Corporation (USA) (NASDAQ:SINA) is the 12th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 5.6% on the day. SINA's upside potential is 89.0% based on brokerage analysts' average target price of $105.37. It is trading at 37.9% of its 52-week high of $147.12, and 19.0% above its 52-week low of $46.86. Sohu.com Inc. (NASDAQ:SOHU) is the 13th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 5.4% on the day. SOHU's upside potential is 58.9% based on brokerage analysts' average target price of $78.38. It is trading at 45.1% of its 52-week high of $109.37, and 8.7% above its 52-week low of $45.40. China Kanghui Holdings (ADR) (NYSE:KH) is the 14th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 5.3% on the day. KH's upside potential is 65.0% based on brokerage analysts' average target price of $24.75. It is trading at 56.6% of its 52-week high of $26.50, and 16.1% above its 52-week low of $12.92. PetroChina Company Limited (ADR) (NYSE:PTR) is the 15th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.7% on the day. PTR's upside potential is 25.8% based on brokerage analysts' average target price of $150.67. It is trading at 75.4% of its 52-week high of $158.83, and 7.6% above its 52-week low of $111.29. VanceInfo Technologies Inc.(ADR) (NYSE:VIT) is the 16th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.7% on the day. VIT's upside potential is 108.7% based on brokerage analysts' average target price of $18.24. It is trading at 23.0% of its 52-week high of $37.99, and 41.2% above its 52-week low of $6.19. NetEase.com, Inc. (ADR) (NASDAQ:NTES) is the 17th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.4% on the day. NTES's upside potential is 18.8% based on brokerage analysts' average target price of $56.66. It is trading at 86.7% of its 52-week high of $55.00, and 35.5% above its 52-week low of $35.20. Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is the 18th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.2% on the day. MPEL's upside potential is 67.6% based on brokerage analysts' average target price of $15.37. It is trading at 56.8% of its 52-week high of $16.15, and 49.6% above its 52-week low of $6.13. Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) is the 19th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.0% on the day. CTRP's upside potential is 89.0% based on brokerage analysts' average target price of $44.30. It is trading at 46.4% of its 52-week high of $50.57, and 4.1% above its 52-week low of $22.52. AutoNavi Holdings Ltd (ADR) (NASDAQ:AMAP) is the 20th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 3.9% on the day. AMAP's upside potential is 145.5% based on brokerage analysts' average target price of $22.83. It is trading at 46.0% of its 52-week high of $20.20, and 4.8% above its 52-week low of $8.87.
ConAgra Rolls as Market Rallies — Tuesday’s IP Market Recap
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace There's nothing sexy about packaged-food companies, but try telling ConAgra (NYSE: CAG ) investors not to be a little excited after Tuesday's earnings "faceoff" with rival General Mills (NYSE: GIS ). ConAgra jumped 4% on Tuesday after beating Wall Street expectations for its fiscal second quarter. ConAgra reported a net income decline of 15% from the year-ago period. However, earnings of 47 cents per share, excluding one-time items, still were four cents higher than anticipated. ConAgra saw a sales increase of 16% in its commercial foods segment, mostly on the strength of price hikes, and it also maintained current guidance for the fiscal year, with growth still expected in the low- to mid-single digits. General Mills' report wasn't nearly as positive — net income fell 27%, with adjusted earnings of 76 cents per share coming in under Thomson Reuters I/B/E/S forecasts calling for 79 cents. CEO Don Mulligan said the acquisition of Yoplait took a toll on gross margins. The company did maintain guidance at EPS of $2.59 to $2.61. GIS shares dipped less than 1% on the news. General Mills was in a minority of declining stocks Tuesday, as a better-than-expected report on U.S. housing starts sparked the markets to life, sending the Dow Jones up more than 335 points in a pre-Christmas rally that especially shone on the banking and tech sectors. Big winners included
6 Companies Dividend Investors Can Count On in Retirement
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace When investing for income, many retirees focus on the dividend stream. Living off dividends in retirement is helpful in creating a consistent stream of income because dividends do not fluctuate as wildly as stock prices do. Focusing only on the distributions, however, without giving much thought to anything beyond the juicy current yield, could be dangerous . Dividend investing is a process with several stages to minimize risk of income reduction in retirement. The first stage should be selecting quality income candidates from a pool of securities that have certain characteristics the dividend investor is looking for. For example, I tend to purchase companies that have consistently raised dividends for at least 10 years in a row. As a result, I start my screen with the list of Dividend Achievers . The second stage should be applying a set of entry criteria to the list of qualified candidates to narrow it down to a more manageable list for further research. This set of criteria should reflect important points of the investor's strategy, determined by their experience in the markets and risk tolerance. The next stage should be analyzing each security in detail. Given the wealth of data on the Internet these days, many investors tend to focus on the quantitative side of analysis. While it is helpful to see the trends behind the data, and it is fun to project past results, investors should not stop there. Evaluating qualitative characteristics such as branding, product mix, competitive advantages , strengths, weaknesses, opportunities, trends and industry factors should be an important part of the analysis toolset. Obtaining an understanding of the business by reading annual reports or research reports and news stories, as well as observing the business operations in person, also would add to the investment evaluation of the business. While creating a diversified income stream is important, investors also should not forget about capital gains . It is important to understand where the distributions are being derived. In certain investments, investors were receiving a large portion of the distribution as a return of capital, rather than income. While the cash flow was high enough to lure investors into the high-yielding investment, the security was paying these distributions on borrowed time. Once the capital base was depleted, investors would end up with no income and their security might be worthless. One such security is U.S. oil and gas royalty trusts. Most of these pass-through entities tend to pay high current distributions every month out of their royalty interests in oil and gas fields. As these fields get depleted, however, there comes a time when there revenues will run out, and thus there will be no profits to distribute to shareholders. A larger portion of the current distributions of these businesses represents a return of capital, which is logical given the fact that for every barrel of oil equivalents pumped out of the ground, there is one less barrel to be pumped in the future. Once all the barrels in the reserve have been depleted, there will be no more oil to be produced and sold. Examples include BP Prudhoe Bay Royalty Trust (NYSE: BPT ), Hugoton Royalty Trust (NYSE: HGT ) and San Juan Basin Royalty Trust (NYSE: SJT ).
Gold Futures Climb $21, Eye Key Technical Level
Gold futures settled substantially higher on Tuesday as the COMEX February 2012
contract climbed $20.90, or 1.3%, to $1,617.60 per ounce.
contract climbed $20.90, or 1.3%, to $1,617.60 per ounce.
ConAgra Rolls as Market Rallies — Tuesday’s IP Market Recap
There's nothing sexy about packaged-food companies, but try telling ConAgra
(NYSE: CAG ) investors not to be a little excited after Tuesday's earnings
"faceoff" with rival General Mills (NYSE: GIS ). ConAgra jumped 4% on
Tuesday after beating Wall Street expectations for its fiscal second quarter.
ConAgra reported a net income decline of 15% from the year-ago period. However,
earnings of 47 cents per share, excluding one-time items, still were four cents
higher than anticipated. ConAgra saw a sales increase of 16% in its commercial
foods segment, mostly on the strength of price hikes, and it also maintained
current guidance for the fiscal year, with growth still expected in the low- to
mid-single digits. General Mills' report wasn't nearly as positive net
income fell 27%, with adjusted earnings of 76 cents per share coming in under
Thomson Reuters I/B/E/S forecasts calling for 79 cents. CEO Don Mulligan said
the acquisition of Yoplait took a toll on gross margins. The company did
maintain guidance at EPS of $2.59 to $2.61. GIS shares dipped less than 1% on
the news. General Mills was in a minority of declining stocks Tuesday, as a
better-than-expected report on U.S. housing starts sparked the markets to life,
sending the Dow Jones up more than 335 points in a pre-Christmas rally that
especially shone on the banking and tech sectors. Big winners included
(NYSE: CAG ) investors not to be a little excited after Tuesday's earnings
"faceoff" with rival General Mills (NYSE: GIS ). ConAgra jumped 4% on
Tuesday after beating Wall Street expectations for its fiscal second quarter.
ConAgra reported a net income decline of 15% from the year-ago period. However,
earnings of 47 cents per share, excluding one-time items, still were four cents
higher than anticipated. ConAgra saw a sales increase of 16% in its commercial
foods segment, mostly on the strength of price hikes, and it also maintained
current guidance for the fiscal year, with growth still expected in the low- to
mid-single digits. General Mills' report wasn't nearly as positive net
income fell 27%, with adjusted earnings of 76 cents per share coming in under
Thomson Reuters I/B/E/S forecasts calling for 79 cents. CEO Don Mulligan said
the acquisition of Yoplait took a toll on gross margins. The company did
maintain guidance at EPS of $2.59 to $2.61. GIS shares dipped less than 1% on
the news. General Mills was in a minority of declining stocks Tuesday, as a
better-than-expected report on U.S. housing starts sparked the markets to life,
sending the Dow Jones up more than 335 points in a pre-Christmas rally that
especially shone on the banking and tech sectors. Big winners included
Top-Performing U.S.-Listed Chinese Stocks (Dec 20, 2011)
Below are the latest top-performing U.S.-listed Chinese stocks. Yingli Green
Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) is the best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 16.1% on the day. YGEs upside potential is
28.6% based on brokerage analysts average target price of $5.29. It is trading
at 30.2% of its 52-week high of $13.59, and 49.5% above its 52-week low of
$2.75. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) is the second
best-performing U.S.-listed Chinese stock on Dec. 20. It was up 13.8% on the
day. JASOs upside potential is 124.6% based on brokerage analysts average target
price of $3.14. It is trading at 16.3% of its 52-week high of $8.57, and 15.7%
above its 52-week low of $1.21. Trina Solar Limited (ADR) (NYSE:TSL) is the
third best-performing U.S.-listed Chinese stock on Dec. 20. It was up 10.4% on
the day. TSLs upside potential is 84.0% based on brokerage analysts average
target price of $13.07. It is trading at 22.8% of its 52-week high of $31.08,
and 34.5% above its 52-week low of $5.28. E Commerce China Dangdang Inc (ADR)
(NYSE:DANG) is the fourth best-performing U.S.-listed Chinese stock on Dec. 20.
It was up 9.1% on the day. DANGs upside potential is 116.5% based on brokerage
analysts average target price of $9.83. It is trading at 12.5% of its 52-week
high of $36.40, and 10.5% above its 52-week low of $4.11. Spreadtrum
Communications, Inc (ADR) (NASDAQ:SPRD) is the fifth best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 8.9% on the day. SPRDs upside potential is
43.0% based on brokerage analysts average target price of $30.58. It is trading
at 71.3% of its 52-week high of $29.98, and 148.9% above its 52-week low of
$8.59. ReneSola Ltd. (ADR) (NYSE:SOL) is the sixth best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 8.8% on the day. SOLs upside potential is
77.7% based on brokerage analysts average target price of $2.86. It is trading
at 12.2% of its 52-week high of $13.25, and 11.0% above its 52-week low of
$1.45. iSoftStone Holdings Ltd (ADR) (NYSE:ISS) is the seventh best-performing
U.S.-listed Chinese stock on Dec. 20. It was up 8.5% on the day. ISSs upside
potential is 104.5% based on brokerage analysts average target price of $17.20.
It is trading at 37.2% of its 52-week high of $22.63, and 48.6% above its
52-week low of $5.66. Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) is the
eighth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 8.3% on
the day. STPs upside potential is 89.4% based on brokerage analysts average
target price of $4.43. It is trading at 21.6% of its 52-week high of $10.83, and
37.6% above its 52-week low of $1.70. Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the
ninth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 6.2% on
the day. BIDUs upside potential is 55.3% based on brokerage analysts average
target price of $183.86. It is trading at 71.3% of its 52-week high of $165.96,
and 25.5% above its 52-week low of $94.33. New Oriental Education & Tech Grp
(ADR) (NYSE:EDU) is the 10th best-performing U.S.-listed Chinese stock on Dec.
20. It was up 6.0% on the day. EDUs upside potential is 55.1% based on brokerage
analysts average target price of $35.30. It is trading at 65.4% of its 52-week
high of $34.77, and 10.4% above its 52-week low of $20.61. Perfect World Co.,
Ltd. (ADR) (NASDAQ:PWRD) is the 11th best-performing U.S.-listed Chinese stock
on Dec. 20. It was up 5.8% on the day. PWRDs upside potential is 111.3% based on
brokerage analysts average target price of $24.00. It is trading at 39.0% of its
52-week high of $29.10, and 26.2% above its 52-week low of $9.00. SINA
Corporation (USA) (NASDAQ:SINA) is the 12th best-performing U.S.-listed Chinese
stock on Dec. 20. It was up 5.6% on the day. SINAs upside potential is 89.0%
based on brokerage analysts average target price of $105.37. It is trading at
37.9% of its 52-week high of $147.12, and 19.0% above its 52-week low of $46.86.
Sohu.com Inc. (NASDAQ:SOHU) is the 13th best-performing U.S.-listed Chinese
stock on Dec. 20. It was up 5.4% on the day. SOHUs upside potential is 58.9%
based on brokerage analysts average target price of $78.38. It is trading at
45.1% of its 52-week high of $109.37, and 8.7% above its 52-week low of $45.40.
China Kanghui Holdings (ADR) (NYSE:KH) is the 14th best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 5.3% on the day. KHs upside potential is
65.0% based on brokerage analysts average target price of $24.75. It is trading
at 56.6% of its 52-week high of $26.50, and 16.1% above its 52-week low of
$12.92. PetroChina Company Limited (ADR) (NYSE:PTR) is the 15th best-performing
U.S.-listed Chinese stock on Dec. 20. It was up 4.7% on the day. PTRs upside
potential is 25.8% based on brokerage analysts average target price of $150.67.
It is trading at 75.4% of its 52-week high of $158.83, and 7.6% above its
52-week low of $111.29. VanceInfo Technologies Inc.(ADR) (NYSE:VIT) is the 16th
best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.7% on the day.
VITs upside potential is 108.7% based on brokerage analysts average target price
of $18.24. It is trading at 23.0% of its 52-week high of $37.99, and 41.2% above
its 52-week low of $6.19. NetEase.com, Inc. (ADR) (NASDAQ:NTES) is the 17th
best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.4% on the day.
NTESs upside potential is 18.8% based on brokerage analysts average target price
of $56.66. It is trading at 86.7% of its 52-week high of $55.00, and 35.5% above
its 52-week low of $35.20. Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is
the 18th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.2% on
the day. MPELs upside potential is 67.6% based on brokerage analysts average
target price of $15.37. It is trading at 56.8% of its 52-week high of $16.15,
and 49.6% above its 52-week low of $6.13. Ctrip.com International, Ltd. (ADR)
(NASDAQ:CTRP) is the 19th best-performing U.S.-listed Chinese stock on Dec. 20.
It was up 4.0% on the day. CTRPs upside potential is 89.0% based on brokerage
analysts average target price of $44.30. It is trading at 46.4% of its 52-week
high of $50.57, and 4.1% above its 52-week low of $22.52. AutoNavi Holdings Ltd
(ADR) (NASDAQ:AMAP) is the 20th best-performing U.S.-listed Chinese stock on
Dec. 20. It was up 3.9% on the day. AMAPs upside potential is 145.5% based on
brokerage analysts average target price of $22.83. It is trading at 46.0% of its
52-week high of $20.20, and 4.8% above its 52-week low of $8.87.
Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) is the best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 16.1% on the day. YGEs upside potential is
28.6% based on brokerage analysts average target price of $5.29. It is trading
at 30.2% of its 52-week high of $13.59, and 49.5% above its 52-week low of
$2.75. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) is the second
best-performing U.S.-listed Chinese stock on Dec. 20. It was up 13.8% on the
day. JASOs upside potential is 124.6% based on brokerage analysts average target
price of $3.14. It is trading at 16.3% of its 52-week high of $8.57, and 15.7%
above its 52-week low of $1.21. Trina Solar Limited (ADR) (NYSE:TSL) is the
third best-performing U.S.-listed Chinese stock on Dec. 20. It was up 10.4% on
the day. TSLs upside potential is 84.0% based on brokerage analysts average
target price of $13.07. It is trading at 22.8% of its 52-week high of $31.08,
and 34.5% above its 52-week low of $5.28. E Commerce China Dangdang Inc (ADR)
(NYSE:DANG) is the fourth best-performing U.S.-listed Chinese stock on Dec. 20.
It was up 9.1% on the day. DANGs upside potential is 116.5% based on brokerage
analysts average target price of $9.83. It is trading at 12.5% of its 52-week
high of $36.40, and 10.5% above its 52-week low of $4.11. Spreadtrum
Communications, Inc (ADR) (NASDAQ:SPRD) is the fifth best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 8.9% on the day. SPRDs upside potential is
43.0% based on brokerage analysts average target price of $30.58. It is trading
at 71.3% of its 52-week high of $29.98, and 148.9% above its 52-week low of
$8.59. ReneSola Ltd. (ADR) (NYSE:SOL) is the sixth best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 8.8% on the day. SOLs upside potential is
77.7% based on brokerage analysts average target price of $2.86. It is trading
at 12.2% of its 52-week high of $13.25, and 11.0% above its 52-week low of
$1.45. iSoftStone Holdings Ltd (ADR) (NYSE:ISS) is the seventh best-performing
U.S.-listed Chinese stock on Dec. 20. It was up 8.5% on the day. ISSs upside
potential is 104.5% based on brokerage analysts average target price of $17.20.
It is trading at 37.2% of its 52-week high of $22.63, and 48.6% above its
52-week low of $5.66. Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) is the
eighth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 8.3% on
the day. STPs upside potential is 89.4% based on brokerage analysts average
target price of $4.43. It is trading at 21.6% of its 52-week high of $10.83, and
37.6% above its 52-week low of $1.70. Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the
ninth best-performing U.S.-listed Chinese stock on Dec. 20. It was up 6.2% on
the day. BIDUs upside potential is 55.3% based on brokerage analysts average
target price of $183.86. It is trading at 71.3% of its 52-week high of $165.96,
and 25.5% above its 52-week low of $94.33. New Oriental Education & Tech Grp
(ADR) (NYSE:EDU) is the 10th best-performing U.S.-listed Chinese stock on Dec.
20. It was up 6.0% on the day. EDUs upside potential is 55.1% based on brokerage
analysts average target price of $35.30. It is trading at 65.4% of its 52-week
high of $34.77, and 10.4% above its 52-week low of $20.61. Perfect World Co.,
Ltd. (ADR) (NASDAQ:PWRD) is the 11th best-performing U.S.-listed Chinese stock
on Dec. 20. It was up 5.8% on the day. PWRDs upside potential is 111.3% based on
brokerage analysts average target price of $24.00. It is trading at 39.0% of its
52-week high of $29.10, and 26.2% above its 52-week low of $9.00. SINA
Corporation (USA) (NASDAQ:SINA) is the 12th best-performing U.S.-listed Chinese
stock on Dec. 20. It was up 5.6% on the day. SINAs upside potential is 89.0%
based on brokerage analysts average target price of $105.37. It is trading at
37.9% of its 52-week high of $147.12, and 19.0% above its 52-week low of $46.86.
Sohu.com Inc. (NASDAQ:SOHU) is the 13th best-performing U.S.-listed Chinese
stock on Dec. 20. It was up 5.4% on the day. SOHUs upside potential is 58.9%
based on brokerage analysts average target price of $78.38. It is trading at
45.1% of its 52-week high of $109.37, and 8.7% above its 52-week low of $45.40.
China Kanghui Holdings (ADR) (NYSE:KH) is the 14th best-performing U.S.-listed
Chinese stock on Dec. 20. It was up 5.3% on the day. KHs upside potential is
65.0% based on brokerage analysts average target price of $24.75. It is trading
at 56.6% of its 52-week high of $26.50, and 16.1% above its 52-week low of
$12.92. PetroChina Company Limited (ADR) (NYSE:PTR) is the 15th best-performing
U.S.-listed Chinese stock on Dec. 20. It was up 4.7% on the day. PTRs upside
potential is 25.8% based on brokerage analysts average target price of $150.67.
It is trading at 75.4% of its 52-week high of $158.83, and 7.6% above its
52-week low of $111.29. VanceInfo Technologies Inc.(ADR) (NYSE:VIT) is the 16th
best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.7% on the day.
VITs upside potential is 108.7% based on brokerage analysts average target price
of $18.24. It is trading at 23.0% of its 52-week high of $37.99, and 41.2% above
its 52-week low of $6.19. NetEase.com, Inc. (ADR) (NASDAQ:NTES) is the 17th
best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.4% on the day.
NTESs upside potential is 18.8% based on brokerage analysts average target price
of $56.66. It is trading at 86.7% of its 52-week high of $55.00, and 35.5% above
its 52-week low of $35.20. Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is
the 18th best-performing U.S.-listed Chinese stock on Dec. 20. It was up 4.2% on
the day. MPELs upside potential is 67.6% based on brokerage analysts average
target price of $15.37. It is trading at 56.8% of its 52-week high of $16.15,
and 49.6% above its 52-week low of $6.13. Ctrip.com International, Ltd. (ADR)
(NASDAQ:CTRP) is the 19th best-performing U.S.-listed Chinese stock on Dec. 20.
It was up 4.0% on the day. CTRPs upside potential is 89.0% based on brokerage
analysts average target price of $44.30. It is trading at 46.4% of its 52-week
high of $50.57, and 4.1% above its 52-week low of $22.52. AutoNavi Holdings Ltd
(ADR) (NASDAQ:AMAP) is the 20th best-performing U.S.-listed Chinese stock on
Dec. 20. It was up 3.9% on the day. AMAPs upside potential is 145.5% based on
brokerage analysts average target price of $22.83. It is trading at 46.0% of its
52-week high of $20.20, and 4.8% above its 52-week low of $8.87.
Microsoft Corporation (NASDAQ:MSFT) Bringing Kinect To Hospitals
Microsoft Corporation (NASDAQ:MSFT)'s Kinect effect has reached into
hospitals and senior centers. Microsoft Corporation (NASDAQ:MSFT) Bringing
Kinect To Hospitals It has been reported that Microsoft Corporation
(NASDAQ:MSFT) Kinect for Xbox 360 is being used to measure and monitor subtle
changes in the gait and movement of older people. Doctors are also using
Microsoft Corporation (NASDAQ:MSFT) Kinect to help stroke patients regain
movement, while surgeons are using it to access information without leaving the
operating room and in the process sacrificing sterility. Healthcare workers are
also using it to help with physical therapy and children with developmental
disabilities or Attention Deficit Hyperactivity Disorder (ADHD). Bill Crounse, a
medical doctor and Microsoft Corporation (NASDAQ:MSFT)s senior director of
worldwide health, said that, Honestly, what we know about here at Microsoft
Corporation (NASDAQ:MSFT) is but a tiny fraction of what is actually going on.
Everywhere I go in the world every hospital, college or public health
organization, people are already doing something with Kinect or they plan to.
Microsoft Corp. (NASDAQ:MSFT) stocks are currently standing at 25.53. Price
History Last Price: 25.53 52 Week Low / High: 23.65 / 29.46 50 Day Moving
Average: 26.16 6 Month Price Change %: 7.2% 12 Month Price Change %: -7.1%
hospitals and senior centers. Microsoft Corporation (NASDAQ:MSFT) Bringing
Kinect To Hospitals It has been reported that Microsoft Corporation
(NASDAQ:MSFT) Kinect for Xbox 360 is being used to measure and monitor subtle
changes in the gait and movement of older people. Doctors are also using
Microsoft Corporation (NASDAQ:MSFT) Kinect to help stroke patients regain
movement, while surgeons are using it to access information without leaving the
operating room and in the process sacrificing sterility. Healthcare workers are
also using it to help with physical therapy and children with developmental
disabilities or Attention Deficit Hyperactivity Disorder (ADHD). Bill Crounse, a
medical doctor and Microsoft Corporation (NASDAQ:MSFT)s senior director of
worldwide health, said that, Honestly, what we know about here at Microsoft
Corporation (NASDAQ:MSFT) is but a tiny fraction of what is actually going on.
Everywhere I go in the world every hospital, college or public health
organization, people are already doing something with Kinect or they plan to.
Microsoft Corp. (NASDAQ:MSFT) stocks are currently standing at 25.53. Price
History Last Price: 25.53 52 Week Low / High: 23.65 / 29.46 50 Day Moving
Average: 26.16 6 Month Price Change %: 7.2% 12 Month Price Change %: -7.1%
Google Inc. (NASDAQ:GOOG) Expands Google+ Features
Google Inc. (NASDAQ:GOOG) has added some new features to its social network,
Google+. Google Inc. (NASDAQ:GOOG) Expands Google+ Features The search titan
Google Inc. (NASDAQ:GOOG) will add new features to its social networking site
Google+ over the next few days to improve the functionality of the site. The new
updates include tweaks to notification settings, revamped photo lightbox
technology and multi-manager support for Google+ Pages. Google Inc.
(NASDAQ:GOOG)'s vice president of Google+ products Bradley Horowitz said,
"Today were pleased to announce a goodie basket full of Google+ features and
functionality for you to unpack and enjoy over the holidays. Some of these were
on nearly everyones wishlist and some we hope will be welcome surprises. These
features will be rolling out over the next couple of days, and we hope youll
find them useful this holiday season and beyond". Google Inc. (NASDAQ:GOOG)
shares were at 621.83 at the end of the last days trading. Theres been a 14.5%
change in the stock price over the past 3 months. Google Inc. (NASDAQ:GOOG)
Analyst Advice Consensus Opinion: Moderate Buy Mean recommendation: 1.17
(1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.17 Zacks Rank: 7 out of 30 in the
industry
Google+. Google Inc. (NASDAQ:GOOG) Expands Google+ Features The search titan
Google Inc. (NASDAQ:GOOG) will add new features to its social networking site
Google+ over the next few days to improve the functionality of the site. The new
updates include tweaks to notification settings, revamped photo lightbox
technology and multi-manager support for Google+ Pages. Google Inc.
(NASDAQ:GOOG)'s vice president of Google+ products Bradley Horowitz said,
"Today were pleased to announce a goodie basket full of Google+ features and
functionality for you to unpack and enjoy over the holidays. Some of these were
on nearly everyones wishlist and some we hope will be welcome surprises. These
features will be rolling out over the next couple of days, and we hope youll
find them useful this holiday season and beyond". Google Inc. (NASDAQ:GOOG)
shares were at 621.83 at the end of the last days trading. Theres been a 14.5%
change in the stock price over the past 3 months. Google Inc. (NASDAQ:GOOG)
Analyst Advice Consensus Opinion: Moderate Buy Mean recommendation: 1.17
(1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.17 Zacks Rank: 7 out of 30 in the
industry
Crocodile Gold’s Maud Creek Deposit Proceeds to Pre-Feasibility
Crocodile Gold (CRK.TSX) announced the completion of a Mine and Development
Options Study to ascertain the optimum financial development scenario for its
Maud Creek Deposit in Australia.
Options Study to ascertain the optimum financial development scenario for its
Maud Creek Deposit in Australia.
Klondex Mines Appoints New VP, Exploration
Klondex Mines (KDX.TSX) announced the appointment of Dean T. "Ted" Wilton,
as Vice President, Exploration.
as Vice President, Exploration.
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB Rapid
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
Top 10 Fastest-Growing Biotech Stocks: UTHR, ONXX, ACOR, JAZZ, CELG, SHP, VIVO, PRXL, GILD, CVD (Dec 20, 2011)
Below are the top 10 fastest-growing Biotech stocks, based on the average
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB Rapid
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
Top 10 Fastest-Growing Biotech Stocks: UTHR, ONXX, ACOR, JAZZ, CELG, SHP, VIVO, PRXL, GILD, CVD (Dec 20, 2011)
Below are the top 10 fastest-growing Biotech stocks, based on the average
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB Rapid
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
Top 10 Fastest-Growing Biotech Stocks: UTHR, ONXX, ACOR, JAZZ, CELG, SHP, VIVO, PRXL, GILD, CVD (Dec 20, 2011)
Below are the top 10 fastest-growing Biotech stocks, based on the average
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB Rapid
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
Top 10 Small Cap Stocks with Highest Upside: NAK, GBG, AMRN, CLWR, CETV, ITMN, THM, CENT, NOAH, MTOR (Dec 20, 2011)
Below are the top 10 Small Cap stocks with highest upside potential, based on
the difference between current price and Wall Street analysts average target
price. One Chinese company (NOAH) is on the list. Northern Dynasty Minerals Ltd.
(USA) (AMEX:NAK) has the 1st highest upside potential in this segment of the
market. Its upside is 355.5%. Its consensus target price is $26.92 based on the
average of all estimates. Great Basin Gold Ltd. (USA) (AMEX:GBG) has the 2nd
highest upside potential in this segment of the market. Its upside is 309.8%.
Its consensus target price is $3.62 based on the average of all estimates.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has the 3rd highest upside potential
in this segment of the market. Its upside is 262.0%. Its consensus target price
is $22.56 based on the average of all estimates. Clearwire Corporation
(NASDAQ:CLWR) has the 4th highest upside potential in this segment of the
market. Its upside is 237.4%. Its consensus target price is $6.85 based on the
average of all estimates. Central European Media Enterprises Ltd. (NASDAQ:CETV)
has the 5th highest upside potential in this segment of the market. Its upside
is 220.5%. Its consensus target price is $20.03 based on the average of all
estimates. InterMune, Inc. (NASDAQ:ITMN) has the 6th highest upside potential in
this segment of the market. Its upside is 216.8%. Its consensus target price is
$34.81 based on the average of all estimates. International Tower Hill Mines
Ltd(USA] (AMEX:THM) has the 7th highest upside potential in this segment of the
market. Its upside is 204.6%. Its consensus target price is $10.96 based on the
average of all estimates. Central Garden & Pet Co. (NASDAQ:CENT) has the 8th
highest upside potential in this segment of the market. Its upside is 188.3%.
Its consensus target price is $22.00 based on the average of all estimates. Noah
Holdings Limited (ADR) (NYSE:NOAH) has the 9th highest upside potential in this
segment of the market. Its upside is 187.4%. Its consensus target price is
$19.92 based on the average of all estimates. Meritor Inc (NYSE:MTOR) has the
10th highest upside potential in this segment of the market. Its upside is
186.3%. Its consensus target price is $14.37 based on the average of all
estimates.
the difference between current price and Wall Street analysts average target
price. One Chinese company (NOAH) is on the list. Northern Dynasty Minerals Ltd.
(USA) (AMEX:NAK) has the 1st highest upside potential in this segment of the
market. Its upside is 355.5%. Its consensus target price is $26.92 based on the
average of all estimates. Great Basin Gold Ltd. (USA) (AMEX:GBG) has the 2nd
highest upside potential in this segment of the market. Its upside is 309.8%.
Its consensus target price is $3.62 based on the average of all estimates.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has the 3rd highest upside potential
in this segment of the market. Its upside is 262.0%. Its consensus target price
is $22.56 based on the average of all estimates. Clearwire Corporation
(NASDAQ:CLWR) has the 4th highest upside potential in this segment of the
market. Its upside is 237.4%. Its consensus target price is $6.85 based on the
average of all estimates. Central European Media Enterprises Ltd. (NASDAQ:CETV)
has the 5th highest upside potential in this segment of the market. Its upside
is 220.5%. Its consensus target price is $20.03 based on the average of all
estimates. InterMune, Inc. (NASDAQ:ITMN) has the 6th highest upside potential in
this segment of the market. Its upside is 216.8%. Its consensus target price is
$34.81 based on the average of all estimates. International Tower Hill Mines
Ltd(USA] (AMEX:THM) has the 7th highest upside potential in this segment of the
market. Its upside is 204.6%. Its consensus target price is $10.96 based on the
average of all estimates. Central Garden & Pet Co. (NASDAQ:CENT) has the 8th
highest upside potential in this segment of the market. Its upside is 188.3%.
Its consensus target price is $22.00 based on the average of all estimates. Noah
Holdings Limited (ADR) (NYSE:NOAH) has the 9th highest upside potential in this
segment of the market. Its upside is 187.4%. Its consensus target price is
$19.92 based on the average of all estimates. Meritor Inc (NYSE:MTOR) has the
10th highest upside potential in this segment of the market. Its upside is
186.3%. Its consensus target price is $14.37 based on the average of all
estimates.
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB
December 20th Stocks Gapping Up: AAPL, SLXP, GOLD, PGNX, SYT, AGU, CF, DB Rapid
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
News Network - 31 minutes ago Apple Inc. (Public, NASDAQ:AAPL). Last Market
Price: $390.00, Change +7.79, % Change (2.04%). Shares trade in the range of
$387.26 - $390.48 dollars. Mining - Gold Updates: MDW, RIC, RGLD, GOLD, GRZ -
Emerald Scope
Top 10 Fastest-Growing Biotech Stocks: UTHR, ONXX, ACOR, JAZZ, CELG, SHP, VIVO, PRXL, GILD, CVD (Dec 20, 2011)
Below are the top 10 fastest-growing Biotech stocks, based on the average
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
Top 10 Fastest-Growing Biotech Stocks: UTHR, ONXX, ACOR, JAZZ, CELG, SHP, VIVO, PRXL, GILD, CVD (Dec 20, 2011)
Below are the top 10 fastest-growing Biotech stocks, based on the average
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (SHP) is on the list. United Therapeutics Corporation (NASDAQ:UTHR) is
the first fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 44.8%. This number is based on the average
estimate of 6 brokerage analysts. Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is
the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 31.8%. This number is based on the average
estimate of 4 brokerage analysts. Acorda Therapeutics Inc. (NASDAQ:ACOR) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 29.7%. This number is based on the average estimate
of 3 brokerage analysts. Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 29.4%. This number is based on the average estimate of
3 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 25.0%. This number is based on the average estimate of
15 brokerage analysts. ShangPharma Corp (ADR) (NYSE:SHP) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 19.4%. This number is based on the average estimate of
4 brokerage analysts. Meridian Bioscience, Inc. (NASDAQ:VIVO) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 16.8%. This number is based on the average estimate of
5 brokerage analysts. PAREXEL International Corporation (NASDAQ:PRXL) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 16.5%. This number is based on the average estimate
of 8 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 15.8%. This number is based on the average estimate of
13 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
15.4%. This number is based on the average estimate of 10 brokerage analysts.
5 Stocks I’m Loading Into The New Year
XCSFDHG46767FHJHJF
tdp2664 Penny Stock Live As December comes to a close I’m looking to use my cash and load up with 100% stock heading into January. The following five stocks are companies I currently own or plan to own as a part of loading the boat because I think they will run in 2012. I like PZZI off of $5 dollar support and will look to accumulate 5,000 – 10,000 shares around there. QPSA is a former winner for us back in late October early November and I think 5,000 – 10,000 shares just below $3 is a good entry on that. RENN I’m not as confident because nobody is buying China right now but if it slips to $3 I’ll be looking to pick up a sizable position with a tight stop just in case market sentiment on China doesn’t turn. I already own 25,000 USAT and am at a loss, however I think this stock trades above $2 in 2012 so I’ll be looking to add more size as January comes closer. I’ve followed this company and sector for a year and think that could be one of my bigger scores in early 2012. Finally LQMT for the penny lovers. LQMT is an interesting story given their deal with Apple and Swatch so they definitely have the ability to become popular again in 2012. Given the sell off in December I’ll look to grab a small chunk at some point and let it ride in 2012. Some questions have come up about my new day trade newsletter 'JasonBondPicks Winning Day Trades' – let me address them. 1. Do all of your trades go out by alert? Yes, all of my SWING trades go out by alert, that’s what your subscription is for… ‘JasonBondPicks Winning Swing Trades’ and I do 3-5 swing trades every week. The cost of this newsletter is $295 / quarter or $995 a year. The price range on this newsletter is generally $.25 – $5 so customers know exactly what to expect. These are buy / short with the intention of holding 1-10 days as advertised. I will close the trade on day 1 however if I’m up 10% in a few hours. 2. I see some trades on Profit.ly that didn’t go by alert, why is that? Those are day trades I’m collecting as material to market my new product… ‘JasonBondPicks Winning Day Trades’ and I’ll be doing 5-10 of them a day. The cost of this newsletter will be $1,995 / year and is meant for the guy or gal who want more ideas than my swing trade newsletter and don’t mind sitting in a chat all day to get them. 3. Will existing members get this membership for free? No, I’m sorry but that won’t work well – the idea is to attract guys / gals who want to trade along side of me when I throw $100,000 at a trade for 5 minutes to an hour with the goal of making 1-3%. Carrying over my existing membership would not be wise because a newsletter like this doesn’t apply to everyone, especially the 90% of my existing subscribers who work during the day and only want to follow 3-5 swing trade alerts per week. Anyone who is on the ‘swing trade’ list but wants ‘day trade’ too will be given a hefty discount though. There will be no discount if you opt out of the ‘swing trade newsletter’ for the ‘daytrade’ newsletter. But I’m thinking 50% off for my existing customers who want both. I’m in this to make money but I also try to take care of my guys / gals who support me right now. 4. When will the new ‘Day Trade’ newsletter be ready? My hope is in January but right now we’re moving the ‘Swing Trade’ newsletter to a new platform so that will need to be finished first. I’ll keep you posted but I’ll definitely gunning for early January so we can track a full year worth of day trades. 5. Will day trading take away from your ability to spot good swing trades? Guys, come on with this question!!! I’m at my trading station with 6 monitors 18 hours a day. The ‘Winning Small Cap Swing Trades’ newsletter is designed to send 3-5 alerts a week yet I pass up on at least 3 solid day trades daily because I don’t have a vehicle to sell day trades yet. I’ll always be a swing trader first but there is nothing wrong with scalping some stocks given these choppy markets and more importantly I have a lot of customers who want the ideas.
Todays Low Interest Rates; Mortgages, Adjustable Rates, Home Loans Affordable; Federal Reserve Moves to keep Current Interest Rates USA Lower
XCSFDHG46767FHJHJF
dow2664 Interest rates for adjustable rate mortgages will likely remain unchanged. On the opening market session of this month, the Federal Reserve announced that the average yield for one-year treasury bills would remain unchanged at .11 percent. This was good news for many Americans. Interest rates in America are still at relative lows and The Feds are taking specific action to keep short term interest rates at lower levels. Interest rates for deposits, credit, mortgages and home loans , and adjustable rate mortgages remain affordable while the U.S. economy attempts to make strides in the right direction. Recently, the U.S. economy made some positive gains. The national unemployment rate dropped below the 9 percent level and the number of American filing for first time unemployment benefits dropped lower as well. Both variable are positive signs. The Federal Reserve is working to keep funds available for the American public during this time of recovery. It is also anticipated that as the economy moves towards recovery, the lower rates will help to stimulate and kick start more positive action in the U.S. to help the recovery process along. The housing market is a good place to focus effort. A primary market survey reveals that the average interest rate right now for a 30 year mortgage is at 3.94 percent and the average for a 15 year mortgage home loan is at 3.21 percent. Stephen Johnson
5 Dogs of 2011 With Hope for Better in 2012
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace If every dog has its day, these stocks are overdue. With the help of Capital IQ, we looked at the S&P 500′s 10 worst performers year-to-date as of Dec. 8. We then got rid of stocks where analysts saw no nope of a rebound. Then we cut the list further by keeping only those companies where analysts are forecasting a share price gain by at least 25% over the next year. That left us with five dogs of 2011 that could have their day in 2012. Each company on our list has good reason for its stock’s precipitous decline this year, but there’s also reason to hope for a rebound in 2012. This group, like our recent picks of top performers of 2011 that may rise again in 2012 , is surprisingly diverse — featuring financial service and cable-TV companies along with Netflix, which is ending 2011 as everyone's favorite corporate punching bag. Here’s the list, ranked in descending order of potential upside. Bank of America (NYSE: BAC ) 2011 decline: 58.1% Recent trade: $5.34 Average one-year price target: $9.72 Potential upside: 82% What went wrong? For the Charlotte, N.C.-based financial services firm, the answer is pretty much everything. It lost its ranking as the largest bank by assets to JPMorgan Chase (NYSE: JPM ) and continued to be mired in the mortgage mess it created for itself through its 2008 acquisition of Countrywide. BofA swung to a profit in the third quarter largely due to an accounting gain and the pretax benefits it earned by selling its interest in a Chinese bank. In November, the company announced plans to slash 30,000 workers over the next few years in a bid to save $5 billion annually.
Microsoft Corporation (NASDAQ:MSFT) Launching Social Network?
XCSFDHG46767FHJHJF
tdp2664 E money daily Microsoft Corporation (NASDAQ:MSFT) has launched new social network, so.cl. Microsoft Corporation (NASDAQ:MSFT) Launching Social Network? Reports say that Microsoft Corporation (NASDAQ:MSFT) has rolled out 'so.cl', a new social networking site which experiments with the concept of social search and is meant to help students to share interesting discoveries related to their curriculum with eachother. So.cl, developed by Microsoft Corporation (NASDAQ:MSFT) FUSE Labs, looks like a combination of features from Facebook and Google+. It will have a combination of search, web browsing and social networking features. At present, the site is restricted to few universities like the University of Washington, Syracuse University, New York University and a few other schools. Others who may be interested in this project can express an interest in the project by signing on using their Facebook id or emailing Microsoft. Microsoft Corp. (NASDAQ:MSFT) stocks are currently standing at 25.53. Price History Last Price: 25.53 52 Week Low / High: 23.65 / 29.46 50 Day Moving Average: 26.16 6 Month Price Change %: 7.2% 12 Month Price Change %: -7.1%
Google Inc. (NASDAQ:GOOG) To Face FTC Probe?
XCSFDHG46767FHJHJF
tdp2664 E money daily US senators have urged the FTC to investigate Google Inc. (NASDAQ:GOOG)'s business practices. Google Inc. (NASDAQ:GOOG) To Face FTC Probe? Two US Senators asked the Federal Trade Commission to enquire about the business practices of Google Inc. (NASDAQ:GOOG) and the allegations that the company promotes its own products in search results. Antitrust Committee member Herb Kohl and Mike Lee sent a letter to the FTC chairman Jon Leibowitz urging the FTC to mount an investigation. Adam Kovacevich, a Google Inc. (NASDAQ:GOOG) spokesman, said, "We appreciate that the committee reserved judgment as we continue to cooperate with the FTC. We are committed to competing fairly on the Internet's level playing field". Google Inc. (NASDAQ:GOOG) shares were at 621.83 at the end of the last day’s trading. There’s been a 14.5% movement in the stock price over the past 3 months. Google Inc. (NASDAQ:GOOG) Analyst Advice Consensus Opinion: Moderate Buy Mean recommendation: 1.17 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.17 Zack’s Rank: 7 out of 30 in the industry
Google Inc. (NASDAQ:GOOG) To Face FTC Probe?
US senators have urged the FTC to investigate Google Inc. (NASDAQ:GOOG)'s
business practices. Google Inc. (NASDAQ:GOOG) To Face FTC Probe? Two US Senators
asked the Federal Trade Commission to enquire about the business practices of
Google Inc. (NASDAQ:GOOG) and the allegations that the company promotes its own
products in search results. Antitrust Committee member Herb Kohl and Mike Lee
sent a letter to the FTC chairman Jon Leibowitz urging the FTC to mount an
investigation. Adam Kovacevich, a Google Inc. (NASDAQ:GOOG) spokesman, said,
"We appreciate that the committee reserved judgment as we continue to
cooperate with the FTC. We are committed to competing fairly on the Internet's
level playing field". Google Inc. (NASDAQ:GOOG) shares were at 621.83 at the
end of the last days trading. Theres been a 14.5% movement in the stock price
over the past 3 months. Google Inc. (NASDAQ:GOOG) Analyst Advice Consensus
Opinion: Moderate Buy Mean recommendation: 1.17 (1=Strong Buy, 5=Strong Sell) 3
Months Ago: 1.17 Zacks Rank: 7 out of 30 in the industry
business practices. Google Inc. (NASDAQ:GOOG) To Face FTC Probe? Two US Senators
asked the Federal Trade Commission to enquire about the business practices of
Google Inc. (NASDAQ:GOOG) and the allegations that the company promotes its own
products in search results. Antitrust Committee member Herb Kohl and Mike Lee
sent a letter to the FTC chairman Jon Leibowitz urging the FTC to mount an
investigation. Adam Kovacevich, a Google Inc. (NASDAQ:GOOG) spokesman, said,
"We appreciate that the committee reserved judgment as we continue to
cooperate with the FTC. We are committed to competing fairly on the Internet's
level playing field". Google Inc. (NASDAQ:GOOG) shares were at 621.83 at the
end of the last days trading. Theres been a 14.5% movement in the stock price
over the past 3 months. Google Inc. (NASDAQ:GOOG) Analyst Advice Consensus
Opinion: Moderate Buy Mean recommendation: 1.17 (1=Strong Buy, 5=Strong Sell) 3
Months Ago: 1.17 Zacks Rank: 7 out of 30 in the industry
Top 10 Fastest-Growing U.S.-Listed Chinese Stocks: December 20, 2010, YOKU, MPEL, QIHU, DANG, BONA, BIDU, NOAH, NQ, CHU (Dec 20, 2011)
Below are the top 10 fastest-growing U.S.-listed Chinese stocks, based on the
average long-term earnings growth rate estimated by Wall Street analysts.
Jiayuan.com International Ltd (NASDAQ:DATE) is the first fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
60.3%. This number is based on the average estimate of 2 brokerage analysts.
Youku.com Inc (ADR) (NYSE:YOKU) is the second fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 56.9%.
This number is based on the average estimate of 3 brokerage analysts. Melco
Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is the third fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
56.3%. This number is based on the average estimate of 2 brokerage analysts.
Qihoo 360 Technology Co Ltd (NYSE:QIHU) is the fourth fastest-growing stock in
this segment of the market. Its long-term annual EPS growth is expected to be
56.0%. This number is based on the average estimate of 2 brokerage analysts. E
Commerce China Dangdang Inc (ADR) (NYSE:DANG) is the fifth fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
53.3%. This number is based on the average estimate of 3 brokerage analysts.
Bona Film Group Ltd (ADR) (NASDAQ:BONA) is the sixth fastest-growing stock in
this segment of the market. Its long-term annual EPS growth is expected to be
50.4%. This number is based on the average estimate of 3 brokerage analysts.
Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the seventh fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 49.7%.
This number is based on the average estimate of 15 brokerage analysts. Noah
Holdings Limited (ADR) (NYSE:NOAH) is the eighth fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 42.4%.
This number is based on the average estimate of 2 brokerage analysts. NetQin
Mobile Inc (NYSE:NQ) is the ninth fastest-growing stock in this segment of the
market. Its long-term annual EPS growth is expected to be 40.0%. This number is
based on the average estimate of 2 brokerage analysts. China Unicom (Hong Kong)
Limited (ADR) (NYSE:CHU) is the 10th fastest-growing stock in this segment of
the market. Its long-term annual EPS growth is expected to be 32.5%. This number
is based on the average estimate of 2 brokerage analysts.
average long-term earnings growth rate estimated by Wall Street analysts.
Jiayuan.com International Ltd (NASDAQ:DATE) is the first fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
60.3%. This number is based on the average estimate of 2 brokerage analysts.
Youku.com Inc (ADR) (NYSE:YOKU) is the second fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 56.9%.
This number is based on the average estimate of 3 brokerage analysts. Melco
Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is the third fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
56.3%. This number is based on the average estimate of 2 brokerage analysts.
Qihoo 360 Technology Co Ltd (NYSE:QIHU) is the fourth fastest-growing stock in
this segment of the market. Its long-term annual EPS growth is expected to be
56.0%. This number is based on the average estimate of 2 brokerage analysts. E
Commerce China Dangdang Inc (ADR) (NYSE:DANG) is the fifth fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
53.3%. This number is based on the average estimate of 3 brokerage analysts.
Bona Film Group Ltd (ADR) (NASDAQ:BONA) is the sixth fastest-growing stock in
this segment of the market. Its long-term annual EPS growth is expected to be
50.4%. This number is based on the average estimate of 3 brokerage analysts.
Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the seventh fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 49.7%.
This number is based on the average estimate of 15 brokerage analysts. Noah
Holdings Limited (ADR) (NYSE:NOAH) is the eighth fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 42.4%.
This number is based on the average estimate of 2 brokerage analysts. NetQin
Mobile Inc (NYSE:NQ) is the ninth fastest-growing stock in this segment of the
market. Its long-term annual EPS growth is expected to be 40.0%. This number is
based on the average estimate of 2 brokerage analysts. China Unicom (Hong Kong)
Limited (ADR) (NYSE:CHU) is the 10th fastest-growing stock in this segment of
the market. Its long-term annual EPS growth is expected to be 32.5%. This number
is based on the average estimate of 2 brokerage analysts.
Microsoft Corporation (NASDAQ:MSFT) Launching Social Network?
Microsoft Corporation (NASDAQ:MSFT) has launched new social network, so.cl.
Microsoft Corporation (NASDAQ:MSFT) Launching Social Network? Reports say that
Microsoft Corporation (NASDAQ:MSFT) has rolled out 'so.cl', a new social
networking site which experiments with the concept of social search and is meant
to help students to share interesting discoveries related to their curriculum
with eachother. So.cl, developed by Microsoft Corporation (NASDAQ:MSFT) FUSE
Labs, looks like a combination of features from Facebook and Google+. It will
have a combination of search, web browsing and social networking features. At
present, the site is restricted to few universities like the University of
Washington, Syracuse University, New York University and a few other schools.
Others who may be interested in this project can express an interest in the
project by signing on using their Facebook id or emailing Microsoft. Microsoft
Corp. (NASDAQ:MSFT) stocks are currently standing at 25.53. Price History Last
Price: 25.53 52 Week Low / High: 23.65 / 29.46 50 Day Moving Average: 26.16 6
Month Price Change %: 7.2% 12 Month Price Change %: -7.1%
Microsoft Corporation (NASDAQ:MSFT) Launching Social Network? Reports say that
Microsoft Corporation (NASDAQ:MSFT) has rolled out 'so.cl', a new social
networking site which experiments with the concept of social search and is meant
to help students to share interesting discoveries related to their curriculum
with eachother. So.cl, developed by Microsoft Corporation (NASDAQ:MSFT) FUSE
Labs, looks like a combination of features from Facebook and Google+. It will
have a combination of search, web browsing and social networking features. At
present, the site is restricted to few universities like the University of
Washington, Syracuse University, New York University and a few other schools.
Others who may be interested in this project can express an interest in the
project by signing on using their Facebook id or emailing Microsoft. Microsoft
Corp. (NASDAQ:MSFT) stocks are currently standing at 25.53. Price History Last
Price: 25.53 52 Week Low / High: 23.65 / 29.46 50 Day Moving Average: 26.16 6
Month Price Change %: 7.2% 12 Month Price Change %: -7.1%
Top 10 Fastest-Growing NASDAQ Stocks: MMYT, RENT, BONA, BIDU, RLOC, UTHR, QCOR, CTCT, AWAY, QLIK (Dec 20, 2011)
Below are the top 10 fastest-growing stocks in the NASDAQ Composite index,
based on the average long-term earnings growth rate estimated by Wall Street
analysts. Two Chinese companies (BONA, BIDU) are on the list. MakeMyTrip Limited
(NASDAQ:MMYT) is the first fastest-growing stock in this segment of the market.
Its long-term annual EPS growth is expected to be 83.0%. This number is based on
the average estimate of 4 brokerage analysts. Rentrak Corporation (NASDAQ:RENT)
is the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 62.3%. This number is based on the average
estimate of 3 brokerage analysts. Bona Film Group Ltd (ADR) (NASDAQ:BONA) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 50.4%. This number is based on the average estimate
of 3 brokerage analysts. Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 49.7%. This number is based on the average estimate of
15 brokerage analysts. ReachLocal Inc. (NASDAQ:RLOC) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 46.7%. This number is based on the average estimate of
3 brokerage analysts. United Therapeutics Corporation (NASDAQ:UTHR) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 44.8%. This number is based on the average estimate of
6 brokerage analysts. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is the
seventh fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 42.3%. This number is based on the average
estimate of 4 brokerage analysts. Constant Contact, Inc. (NASDAQ:CTCT) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 40.6%. This number is based on the average estimate
of 5 brokerage analysts. HomeAway, Inc. (NASDAQ:AWAY) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 39.8%. This number is based on the average estimate of
3 brokerage analysts. Qlik Technologies Inc (NASDAQ:QLIK) is the 10th
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 39.4%. This number is based on the average estimate of
4 brokerage analysts.
based on the average long-term earnings growth rate estimated by Wall Street
analysts. Two Chinese companies (BONA, BIDU) are on the list. MakeMyTrip Limited
(NASDAQ:MMYT) is the first fastest-growing stock in this segment of the market.
Its long-term annual EPS growth is expected to be 83.0%. This number is based on
the average estimate of 4 brokerage analysts. Rentrak Corporation (NASDAQ:RENT)
is the second fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 62.3%. This number is based on the average
estimate of 3 brokerage analysts. Bona Film Group Ltd (ADR) (NASDAQ:BONA) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 50.4%. This number is based on the average estimate
of 3 brokerage analysts. Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 49.7%. This number is based on the average estimate of
15 brokerage analysts. ReachLocal Inc. (NASDAQ:RLOC) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 46.7%. This number is based on the average estimate of
3 brokerage analysts. United Therapeutics Corporation (NASDAQ:UTHR) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 44.8%. This number is based on the average estimate of
6 brokerage analysts. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is the
seventh fastest-growing stock in this segment of the market. Its long-term
annual EPS growth is expected to be 42.3%. This number is based on the average
estimate of 4 brokerage analysts. Constant Contact, Inc. (NASDAQ:CTCT) is the
eighth fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 40.6%. This number is based on the average estimate
of 5 brokerage analysts. HomeAway, Inc. (NASDAQ:AWAY) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 39.8%. This number is based on the average estimate of
3 brokerage analysts. Qlik Technologies Inc (NASDAQ:QLIK) is the 10th
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 39.4%. This number is based on the average estimate of
4 brokerage analysts.
This Innovative Joint Replacement Stock Will Thrive in 2012
Sometimes life just isnt fair. If youve taken good care of yourself, gotten
lots of exercise ( especially if youve gotten lots of exercise) and been
generally lucky, theres still a good chance youll eventually end up with
osteoarthritis. This degeneration of the joints can be brought on by injury,
genetics or metabolism, but it also can result from simple wear and tear over a
lifetime. More than a third of Americans over the age of 65 wind up with chronic
joint pain. When the pain occurs in knees or hips, as it commonly does, the
answer often has been total joint replacement major surgery requiring months of
recovery, and a procedure done more than 800,000 times a year in the U.S. But
MAKO Surgical (NASDAQ: MAKO ) offers an alternative: MAKOplasty, or the
resurfacing of joints using custom implants and a surgical robot called the RIO.
The technology is behind a compelling razor-and-blade business model that is
driving tremendous revenue growth, but not profits yet. Youve probably heard
how the aging population of Western nations is driving a growth in health care
demand like nothing weve seen before. One accompanying trend is that yesterdays
patients are becoming todays health care consumers informed, opinionated and
involved in every step of their care. Intuitive Surgical (NASDAQ: ISRG ) and its
happy investors discovered that when the company launched its da Vinci surgical
robot, which has become widely used in prostatectomy and gynecologic procedures.
Wooed by lower rates of complication, faster recovery times and better outcomes,
it was patients who to a large degree drove the adoption of the da Vinci from
the experimental fringe to the gold standard of care. We see something similar
at work with MAKO Surgical. Patients typically are back on their feet in a day
and doing normal activities within a few weeks. While the early stage of the
business means theres a lot of risk to this investment, weve seen impressive
growth of the installed base and healthy utilization of the robots already out
in the field. At the end of the third quarter, 97 RIO systems were in use. More
than 10,000 MAKOplasties have been performed since the end of 2007, and 1,813 of
them were performed in the third quarter alone a fast acceleration as
orthopedic thought leaders adopt the procedure and patients begin to catch on.
Management estimates they already have captured close to 10% of the market for
single-compartment knee resurfacing procedures, and the RIO now is starting to
be used for more complex two-compartment procedures. Yet the market is
understated, because many people with osteoarthritis dont seek treatment, having
been told their only option is total knee replacement. Orthopedists anecdotally
report that they are seeing their business grow as they use the RIO because
patients who once were on the sidelines finally seek out care. Thats a path for
MAKO to address a sizable number of the estimated 15 million Americans with knee
osteoarthritis. Where it goes is hard to predict. Even 1% of that total would be
150,000 procedures. At current rates of utilization, that would require about
1,875 RIO systems. Combine that revenue with the roughly $5,000 in implants used
with each procedure, and MAKO could be banking huge profits several years down
the road. Its a long way from here to there, but for the speculative portion of
your portfolio, MAKO could richly reward a little patience. David Gardner
co-founded The Motley Fool with his brother, Tom, in 1993. As Chief Rule
Breaker, David wears many hats, including innovator, stock picker, author,
lecturer and media personality.
lots of exercise ( especially if youve gotten lots of exercise) and been
generally lucky, theres still a good chance youll eventually end up with
osteoarthritis. This degeneration of the joints can be brought on by injury,
genetics or metabolism, but it also can result from simple wear and tear over a
lifetime. More than a third of Americans over the age of 65 wind up with chronic
joint pain. When the pain occurs in knees or hips, as it commonly does, the
answer often has been total joint replacement major surgery requiring months of
recovery, and a procedure done more than 800,000 times a year in the U.S. But
MAKO Surgical (NASDAQ: MAKO ) offers an alternative: MAKOplasty, or the
resurfacing of joints using custom implants and a surgical robot called the RIO.
The technology is behind a compelling razor-and-blade business model that is
driving tremendous revenue growth, but not profits yet. Youve probably heard
how the aging population of Western nations is driving a growth in health care
demand like nothing weve seen before. One accompanying trend is that yesterdays
patients are becoming todays health care consumers informed, opinionated and
involved in every step of their care. Intuitive Surgical (NASDAQ: ISRG ) and its
happy investors discovered that when the company launched its da Vinci surgical
robot, which has become widely used in prostatectomy and gynecologic procedures.
Wooed by lower rates of complication, faster recovery times and better outcomes,
it was patients who to a large degree drove the adoption of the da Vinci from
the experimental fringe to the gold standard of care. We see something similar
at work with MAKO Surgical. Patients typically are back on their feet in a day
and doing normal activities within a few weeks. While the early stage of the
business means theres a lot of risk to this investment, weve seen impressive
growth of the installed base and healthy utilization of the robots already out
in the field. At the end of the third quarter, 97 RIO systems were in use. More
than 10,000 MAKOplasties have been performed since the end of 2007, and 1,813 of
them were performed in the third quarter alone a fast acceleration as
orthopedic thought leaders adopt the procedure and patients begin to catch on.
Management estimates they already have captured close to 10% of the market for
single-compartment knee resurfacing procedures, and the RIO now is starting to
be used for more complex two-compartment procedures. Yet the market is
understated, because many people with osteoarthritis dont seek treatment, having
been told their only option is total knee replacement. Orthopedists anecdotally
report that they are seeing their business grow as they use the RIO because
patients who once were on the sidelines finally seek out care. Thats a path for
MAKO to address a sizable number of the estimated 15 million Americans with knee
osteoarthritis. Where it goes is hard to predict. Even 1% of that total would be
150,000 procedures. At current rates of utilization, that would require about
1,875 RIO systems. Combine that revenue with the roughly $5,000 in implants used
with each procedure, and MAKO could be banking huge profits several years down
the road. Its a long way from here to there, but for the speculative portion of
your portfolio, MAKO could richly reward a little patience. David Gardner
co-founded The Motley Fool with his brother, Tom, in 1993. As Chief Rule
Breaker, David wears many hats, including innovator, stock picker, author,
lecturer and media personality.
Gold & Silver Prices – Daily Outlook December 20
Gold and silver prices slightly declined again on the first day of the week, but
currently they are moderately rising. Today, the U.S. Housing Starts and
building permits report will be published, the Canadian consumer price index and
Bank of Japan announces its monetary policy and rate decision.
currently they are moderately rising. Today, the U.S. Housing Starts and
building permits report will be published, the Canadian consumer price index and
Bank of Japan announces its monetary policy and rate decision.
Top-Performing U.S.-Listed Chinese Stocks (Dec 19, 2011)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the latest top-performing U.S.-listed Chinese stocks. LDK Solar Co., Ltd (ADR) (NYSE:LDK) is the best-performing U.S.-listed Chinese stock on Dec. 19. It was up 11.2% on the day. LDK's upside potential is -9.5% based on brokerage analysts' average target price of $4.48. It is trading at 33.1% of its 52-week high of $14.97, and 94.1% above its 52-week low of $2.55. Simcere Pharmaceutical Group (ADR) (NYSE:SCR) is the second best-performing U.S.-listed Chinese stock on Dec. 19. It was up 2.8% on the day. SCR's upside potential is 34.9% based on brokerage analysts' average target price of $9.98. It is trading at 53.8% of its 52-week high of $13.75, and 3.9% above its 52-week low of $7.12. E-House (China) Holdings Limited (ADR) (NYSE:EJ) is the third best-performing U.S.-listed Chinese stock on Dec. 19. It was up 2.4% on the day. EJ's upside potential is 135.5% based on brokerage analysts' average target price of $10.97. It is trading at 28.7% of its 52-week high of $16.25, and 10.7% above its 52-week low of $4.21. Ambow Education Holding Ltd (ADR) (NYSE:AMBO) is the fourth best-performing U.S.-listed Chinese stock on Dec. 19. It was up 1.5% on the day. AMBO's upside potential is 17.6% based on brokerage analysts' average target price of $8.00. It is trading at 47.2% of its 52-week high of $14.40, and 49.1% above its 52-week low of $4.56. Changyou.com Limited(ADR) (NASDAQ:CYOU) is the fifth best-performing U.S.-listed Chinese stock on Dec. 19. It was up 1.1% on the day. CYOU's upside potential is 86.6% based on brokerage analysts' average target price of $42.88. It is trading at 44.2% of its 52-week high of $52.00, and 11.0% above its 52-week low of $20.71. ReneSola Ltd. (ADR) (NYSE:SOL) is the sixth best-performing U.S.-listed Chinese stock on Dec. 19. It was up 0.7% on the day. SOL's upside potential is 93.3% based on brokerage analysts' average target price of $2.86. It is trading at 11.2% of its 52-week high of $13.25, and 2.1% above its 52-week low of $1.45. ZHONGPIN INC. (NASDAQ:HOGS) is the seventh best-performing U.S.-listed Chinese stock on Dec. 19. It was up 0.0% on the day. HOGS's upside potential is 86.6% based on brokerage analysts' average target price of $15.92. It is trading at 40.5% of its 52-week high of $21.07, and 29.2% above its 52-week low of $6.60. Mindray Medical International Ltd (ADR) (NYSE:MR) is the eighth best-performing U.S.-listed Chinese stock on Dec. 19. It was down 0.1% on the day. MR's upside potential is 25.0% based on brokerage analysts' average target price of $31.13. It is trading at 79.8% of its 52-week high of $31.21, and 17.2% above its 52-week low of $21.25. TAL Education Group (ADR) (NYSE:XRS) is the ninth best-performing U.S.-listed Chinese stock on Dec. 19. It was down 0.3% on the day. XRS's upside potential is 55.1% based on brokerage analysts' average target price of $15.43. It is trading at 61.2% of its 52-week high of $16.25, and 18.3% above its 52-week low of $8.41. Shanda Interactive Entertainment Ltd ADR (NASDAQ:SNDA) is the 10th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 0.3% on the day. SNDA's upside potential is -0.5% based on brokerage analysts' average target price of $39.66. It is trading at 73.5% of its 52-week high of $54.20, and 40.1% above its 52-week low of $28.44. 51job, Inc. (ADR) (NASDAQ:JOBS) is the 11th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 0.4% on the day. JOBS's upside potential is 50.9% based on brokerage analysts' average target price of $64.50. It is trading at 61.2% of its 52-week high of $69.80, and 16.7% above its 52-week low of $36.62. CNinsure Inc. (ADR) (NASDAQ:CISG) is the 12th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 0.4% on the day. CISG's upside potential is 195.5% based on brokerage analysts' average target price of $20.36. It is trading at 33.0% of its 52-week high of $20.88, and 30.5% above its 52-week low of $5.28. China Petroleum & Chemical Corp. (ADR) (NYSE:SNP) is the 13th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 0.8% on the day. SNP's upside potential is 20.9% based on brokerage analysts' average target price of $122.20. It is trading at 90.3% of its 52-week high of $111.92, and 22.6% above its 52-week low of $82.50. AsiaInfo-Linkage, Inc. (NASDAQ:ASIA) is the 14th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 0.9% on the day. ASIA's upside potential is 153.8% based on brokerage analysts' average target price of $17.44. It is trading at 30.0% of its 52-week high of $22.91, and 10.6% above its 52-week low of $6.21. Hollysys Automation Technologies Ltd (NASDAQ:HOLI) is the 15th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 1.2% on the day. HOLI's upside potential is 71.2% based on brokerage analysts' average target price of $13.13. It is trading at 42.3% of its 52-week high of $18.15, and 68.9% above its 52-week low of $4.54. Giant Interactive Group Inc (ADR) (NYSE:GA) is the 16th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 1.2% on the day. GA's upside potential is 74.0% based on brokerage analysts' average target price of $6.98. It is trading at 42.4% of its 52-week high of $9.45, and 32.8% above its 52-week low of $3.02. New Oriental Education & Tech Grp (ADR) (NYSE:EDU) is the 17th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 1.3% on the day. EDU's upside potential is 64.5% based on brokerage analysts' average target price of $35.30. It is trading at 61.7% of its 52-week high of $34.77, and 4.1% above its 52-week low of $20.61. China Real Estate Information Corp (NASDAQ:CRIC) is the 18th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 1.4% on the day. CRIC's upside potential is 94.4% based on brokerage analysts' average target price of $8.05. It is trading at 41.9% of its 52-week high of $9.89, and 12.5% above its 52-week low of $3.68. Focus Media Holding Limited (ADR) (NASDAQ:FMCN) is the 19th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 1.4% on the day. FMCN's upside potential is 110.4% based on brokerage analysts' average target price of $40.23. It is trading at 50.9% of its 52-week high of $37.58, and 117.5% above its 52-week low of $8.79. China Mobile Ltd. (ADR) (NYSE:CHL) is the 20th best-performing U.S.-listed Chinese stock on Dec. 19. It was down 1.6% on the day. CHL's upside potential is 7.8% based on brokerage analysts' average target price of $49.97. It is trading at 89.2% of its 52-week high of $51.98, and 6.6% above its 52-week low of $43.51.
Subscribe to:
Posts (Atom)
LinkWithin
